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Cervical cancer (CC) is the second most common cancer and third in cancer-related deaths 
among women. Developing countries account for most CC-related deaths and are highly 
impacted by CC mortality in young women. In South America, CC is the second most incident 
cause of cancer and first cause of cancer deaths among women 15-44 years. In Colombia, CC is 
the second most common cause of cancer mortality among women. Previous studies conducted 
in Colombia have shown inequities in CC prevention and mortality by different socio- 
demographic factors; however, there is a lack of nationwide studies evaluating these factors 
specifically in young Colombian women. The goal of this thesis was to identify socio-
demographic characteristics associated with awareness of CC primary prevention, access to 
secondary prevention for CC, and CC mortality among young women in Colombia.  
The educational level, type of health insurance, having a rural or urban residence, and region 
of residence of women were common factors related to inequities in CC prevention and mortality 
in Colombia. Women with limited or no education had a reduced probability of having heard of 
HPV vaccination, with differing effects of education by age and region of residence. In the case 
of Pap testing, having a rural residence decreased the odds of Pap testing compared to having an 
urban residence, with wider differences in the odds among women with limited-to-no education 
compared to those with higher education. Additionally, a higher prevalence of no education in 
the neighbourhood where women lived resulted in lower odds of Pap testing in both rural and 
urban areas, especially when comparing women with limited-to-no education to women with a 
secondary or higher education. Measured at the administrative divisions or department level, a 
high prevalence of no education was associated with a low prevalence of Pap testing, specifically 
for departments being at or above the national prevalence of women living in rural areas. 
Similarly, mortality rates were higher among women with limited or no education compared to 
women with higher education, observing wider differences in younger age groups. 
Having subsidised insurance and not having insurance were associated with a decreased 
awareness of HPV vaccination. The effect of type of health insurance on Pap testing varied by 
whether women had a rural or urban residence. Departments with higher prevalences of women 
with subsidised insurance were associated with not having heard of HPV vaccination and not 
having had a Pap test. No significant differences in CC mortality were observed between women 
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with subsidised insurance and those with no insurance. Also, mortality rates for different types of 
health insurance varied for some age groups. 
Women living in rural areas had a reduced awareness of HPV vaccination with variations by 
regions. Having a rural residence also decreased the probability of having Pap testing, 
particularly in some regions of Colombia and among women with no insurance or subsidised 
health insurance. Furthermore, increments in the department percentage of women living in rural 
areas increased the risk ratio of having women who had not had a Pap test in departments 
classified as at or above the national prevalence of no education. In contrast, living in rural areas 
was associated with lower CC mortality rates.  
Women from the Amazon-Orinoquía region had high rates of CC mortality and were less 
likely to have heard of HPV vaccination and have had a Pap test. Several departments located in 
the Amazon-Orinoquía region and a few departments from the Pacific, and Atlantic regions (e.g. 
Chocó, Sucre, and La Guajira) had a high risk of women not having access to primary and 
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CHAPTER 1 – INTRODUCTION 
 
1.1. Background 
Cervical cancer (CC) is the result of a persistent infection by oncogenic human 
papillomaviruses (HPV) (1, 2). High-risk HPV infections related to CC include a number of 
different HPV types, such as HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59 (3). Sexually 
active individuals are at risk of contracting HPV (4), with a global estimated prevalence of 
infection among women between 2% and 35% (5). The number of lifetime sexual partners, co-
infection with the human immunodeficiency virus (HIV) and other sexually transmitted 
infections (STIs), smoking, long-term oral contraceptive use, and having a high parity have been 
associated with an increased risk of CC (6). 
 
Despite being highly preventable (7), CC was ranked globally as the second most common 
cancer as measured by incidence and third in cancer-related deaths for women in 2012 (8). More 
than half a million new cases of CC were diagnosed and more than a quarter million women died 
due to the disease worldwide in 2012 (9). Developing countries are differentially impacted by 
CC mortality (10, 11). While the 2012 age-standardised mortality rate (ASMR) of CC was 3.3 
per 100,000 in more developed regions, in less developed areas the ASMR reached 8.3 per 
100,000 (9). Compared to the world ASMR, higher rates were reported in 2012 for Africa with 
the exception of Northern Africa, Melanesia, South-Central Asia, Central and South America, 
the Caribbean, and South-Eastern Asia (9). Deaths of young women due to CC are also a concern 
in developing countries (10, 11). Out of the more than 200,000 total CC deaths reported 
worldwide in 2010, 78% corresponded to women living in developing countries (11). In the same 
year, 55,900 women between 15 and 49 years of age died due to CC globally; 83% of them were 
from developing countries (11).  
 
In Latin America, CC is the second most common cancer among women (12) and one of the 
main causes of mortality (13). Also, in this region, CC is ranked as the first cause of cancer 
deaths among women between 15 and 44 years (10). Measured as years of life lost (YLL), CC is 
the most important cause of YLL in Latin America and the Caribbean, contributing to more YLL 
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than the acquired immune deficiency syndrome (AIDS) (14). The highest incidence rates of CC 
are in Bolivia, Paraguay, Peru, Venezuela, Ecuador, Brazil, and Colombia (10). Countries 
located in Central America and the Andean region also have high mortality rates due to CC (15).  
 
Cervical cancer affects women and their families worldwide. Physical (16) and psychological 
(7) sequelae are common among women living with CC. The sequelae of CC treatment, 
including infertility (16) or mental health problems (17), could affect the willingness of women 
to continue with proper cancer follow-up (17). In many countries, CC also poses a substantial 
financial burden on families. This burden includes the loss in productivity for the women 
affected by CC (18), high costs associated with medical care (19), and the need for caregivers to 
quit or reduce working hours to look after women affected by CC (20). Cervical cancer impacts 
society due to the loss of mothers (19) and caregivers for other family members (7) who are in 
many cases important contributors to family income (21). Maternal deaths from CC could further 
affect children by impacting their nutritional status (20) or decreasing opportunities to access 
education due to prioritisation of other family needs (21). These effects perpetuate the social 
impact that CC has on education, gender equity, and poverty, especially among women (21). 
Furthermore, it has been estimated that CC is the cancer with the third highest disability-adjusted 
life-years worldwide (22). In the Americas region alone, about US$3.3 billion are lost each year 
due to the economic loss associated with CC deaths (23).  
 
The purpose of this chapter is to highlight international inequities in CC prevention, with a 
focus on the importance of the disease in Colombia. Published reports of inequities related to 
primary and secondary prevention strategies for CC and mortality due to CC are described with 
background information on the social context of Colombia.  
 
1.2. Cervical Cancer Prevention 
Cervical cancer and deaths due to CC can be prevented at different stages through primary, 
secondary, or tertiary strategies (4).  
 
The goal of primary prevention in CC is to prevent disease occurrence among susceptible 
individuals (24) by stopping infection with HPV (4). Given that individuals can be infected with 
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HPV at any time after sexual debut (25), to be effective, primary prevention must begin before 
first sexual activity. Education is key to create awareness (26) and promote CC prevention in the 
population (27). Measures to decrease the risk of infection include educating individuals about 
HPV, risk factors for acquiring a HPV infection, and vaccination against HPV (25, 28). 
Vaccination of women before their exposure to high-risk HPV types has been associated with a 
reduction of pre-invasive cervical lesions (28-30). Indeed, estimates predict a potential 70% 
reduction of CC cases through HPV vaccination (19).  
 
There are three vaccines against HPV available on the market. The quadrivalent vaccine 
(Gardasil®) was licensed in 2006 and protects against HPV 6, 11, 16, and 18. This vaccine could 
be administered to girls and boys starting at 9 years of age (31). The bivalent vaccine (Cervarix®) 
offers protection against HPV 16 and 18 (29) and could be administered to girls from 9 years of 
age (31). Both vaccines should be ideally administered in multiple doses (31, 32). Recently, a 
vaccine with nine strains (Gardasil®9) has been approved for market in the United States (33), 
Canada (34), and the European Union (35). Gardasil®9 offers protection against HPV 6, 11, 16, 
18, 31, 33, 45, 52, and 58 (36). Administration of this vaccine follows the same dosage schedule 
as Gardasil® (37).  
 
Secondary prevention focuses on reducing complications resulting from HPV infection and 
new cases of CC (25) by identifying the disease at early stages through screening and provision 
of timely treatment (38). Secondary CC prevention includes visual screening, tests to detect HPV 
infection, and the conventional cytological screening test or Pap test (39). The Pap test identifies 
early-stage lesions in exfoliated cells collected from the cervix (40) and is one of the most 
popular techniques used for CC screening worldwide (41). Education about the importance of 
CC screening that considers the expectations and concerns of the population is fundamental to 
the success of CC screening programmes (19). 
 
The objective of tertiary CC prevention is timely treatment of invasive CC (4) to limit 
disability in women at late stages of the disease (24). The objectives for three of the four chapters 
of this thesis are focused on primary and secondary prevention of CC. 
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1.3. Inequities in Cervical Cancer 
The health status of individuals varies across populations. Inequities in health occur when 
these variations are unnecessary and avoidable, as well as unfair and unjust (42). Inequities in 
health are closely related to the socioeconomic and political conditions where people live and die 
(43). These conditions are known as the social determinants of health (SDOH) (43). The SDOH 
include factors such as education and housing, as well as access to health care (44). The presence 
of inequities in health is associated with an unfair distribution of the SDOH (45) that 
systematically impact the health of the most socially disadvantaged groups (46). Inadequate 
social policies, economic conditions, and politics between and within countries result in unfair 
distribution of the SDOH (43).  
 
Reducing inequities in health requires eliminating avoidable and unfair factors by “creating 
equal opportunities for health (42).” This reduction could be achieved through the development 
of public policies to address the SDOH (47). Such healthy public policies should help improve 
living and working conditions of people by creating environments where making healthy 
decisions is easy and health care is accessible for all who need it (42). Evidence regarding the 
impact of policies on the SDOH is crucial to reduce inequities in health (43). 
 
Inequities in health are not randomly distributed (48), as is the case of CC. Cervical cancer 
has been described as a disease of poverty (49), given its high impact on women living in 
socially disadvantaged circumstances (50). Despite being preventable, thousands of young 
women are affected by CC globally (10). Cervical cancer disproportionally affects women from 
developing countries who do not seek help until the advanced phases of the disease (7), often 
because inadequate access to CC screening programmes (51). The effects of CC in developing 
countries perpetuate poverty, impacting negatively on education and gender inequity; problems 
which are central to the Millennium Development Goals (21).  
 
1.3.1. Inequities in Cervical Cancer Prevention 
Studies conducted in different countries have associated socio-demographic factors with 
inequities in primary and secondary strategies to prevent CC (4, 19, 38, 40, 41, 52-80). These 
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studies have identified variations in the distribution of risk factors associated with HPV 
knowledge, HPV infection, and HPV vaccination. 
 
Studies of primary prevention of CC consistently report that socio-demographic 
characteristics of individuals increase their risk for exposure to HPV infection. For example, 
sexual debut is earlier for women in low-resource countries (19). Studies conducted in developed 
countries have shown a lower age for sexual debut has also been associated with ethnicity (52-
54); while socioeconomic status has been associated with a younger age of sexual debut in both 
developed and developing countries (53-55).  
 
Other studies conducted in different countries have identified factors associated with 
knowledge of HPV and the importance of HPV vaccination, showing variations according to 
educational level (56-61), health insurance (56), income (58, 62), age (63, 64), race (63), and 
type of job (63). Having a limited awareness of CC prevention and HPV vaccination decreases 
the uptake of HPV vaccination (65-67). Rates of HPV vaccination are reported as low among 
girls from socially deprived groups (68, 69) and some ethnic backgrounds (70, 71). Rates of 
HPV vaccination also vary based on geographic area of residence (70), health insurance status 
(70), and socioeconomic status (70, 71).  
 
Secondary prevention is important in minimising the impact of HPV infection. Cervical 
cancer screening programmes have been associated with a decrease in CC incidence and 
mortality in developed countries (40, 41, 72). It has been estimated that, in countries where CC 
screening programmes have been successfully implemented, CC mortality has been reduced by 
at least 50% (73). This achievement is associated with women having access to repeated 
screening (73) and well organised CC screening programmes (40). In contrast, women living in 
low-resource regions usually have limited access to both Pap testing and proper follow-up once 
diagnosed with CC (38). While more than 75% of women in developed nations participate in CC 
screening programmes, less than 5% of women in developing countries have access to CC 
screening (19). Inadequate infrastructure and resources, competing priorities in health care, and 
fragile health systems are factors affecting the implementation of CC screening programmes in 
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developing countries (4). In areas where CC screening is available, there are also groups of 
women with no access to CC screening programmes (19).  
 
Reports from countries around the world have linked poor participation rates in CC screening 
to age (74), ethnic background (53, 74-78), limited education (53, 74, 78-80), living in rural or 
less developed areas (74, 79), lack of health insurance or access to health care (74, 75, 77, 78, 
80), poor socioeconomic conditions (74, 78), and a lack of knowledge of HPV and CC (79). 
Lack of CC screening, as well as late and inappropriate CC treatment are failures in health 
services that could lead to further socio-demographic disparities in CC mortality (76). 
 
1.3.2. Inequities in Cervical Cancer Mortality 
Mortality due to CC is highest in women living under disadvantaged socio-demographic 
conditions (49). The impact of CC mortality is particularly concerning in young women from 
developing nations (19). Mortality rates in these countries are three times higher than rates 
observed in developed nations (81). Differences in CC mortality between developing and 
developed areas could be attributed to a late diagnosis (82) and limited access to screening and 
treatment (19).  
 
Studies conducted in different countries have shown variations in mortality associated with 
socio-demographic factors including poverty, ethnicity, education, geographic area of residence, 
and health insurance coverage. A CC mortality study that included 184 countries showed that 
increments in the proportion of population living in extreme poverty resulted in more deaths 
from CC, while an increase in health expenditure was associated with reductions in CC mortality 
(81). Studies conducted in Europe and the United States have reported that mortality rates 
increase with decreasing socioeconomic or income status of women (83-85) and in the United 
States with increasing levels of neighbourhood poverty (76). An increasing trend in CC mortality 
rates was found between 1980 and 2000 in Brazilian regions with poor socioeconomic conditions 
(86). Studies in the United States have shown high CC mortality among women who belong to 
certain ethnic groups, such as non-Hispanic black or Hispanic women (76, 87, 88). In contrast, 
studies from the United States, Argentina, and Brazil have reported a lower CC mortality among 
more educated women compared to those with no or limited education (88-90). Also, differences 
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in CC mortality have been studied among areas of residence (84, 85, 89) and health insurance 
status (91). A study conducted in the United States revealed that women living in the south 
eastern and south western regions had higher CC mortality rates compared to other parts of the 
country (85). Another study in the United States showed that the hazard ratio for dying due to 
CC was highest among women who had Medicaid and those with no insurance compared to 
insured women (91). This study also found that women with limited or no insurance coverage 
usually started treatment for CC in more advanced stages of the disease (91). 
 
1.4. Context of This Research 
This thesis will focus on CC in Colombia. Colombia is located in the northern area of South 
America. The country has a total area of 2,070,408 Km2 and is bordered by Panama, Venezuela, 
Ecuador, Peru, and Brazil, sharing maritime borders with Costa Rica, Haiti, Jamaica, the 
Dominican Republic, and Nicaragua (92). Colombia has 32 political administrative divisions 
called departments which, along with the capital district of Bogotá D.C., account for a total of 33 
administrative territories (92) (Fig. 1-1). 
 
Colombia had an estimated population of 48,747,708 in 2016 (93), most (75%) of whom 
resided in urban areas (94). The life expectancy at birth of Colombians in 2015 was 74.8 years, 
with females (78.4 years) having longer average lifespans than males (71.2 years) (95).  
 
Colombia is one of the most inequitable countries in Latin America, where the distribution of 
income varies greatly (96). A 2015 report from the Economic Commission for Latin America 
and the Caribbean revealed that, in Colombia, the richest 1% of the population captures 20% of 
the total income (97). The per capita gross domestic product (GDP) varies largely by department 
(98). Casanare had the highest per capita GDP in 2009, similar to Saudi Arabia, while the 2009 
GDP in Vaupés was similar to Moldova (98). In spite of reductions in poverty levels reported in 
recent years, 21.9% of Colombians lived in deprived conditions in 2014 (99). The proportion of 
the population living in poverty ranges from 25% in the capital of the country to 87% in the 
department of Chocó, with variations within departments and municipalities (98). High poverty 
levels are present in rural areas and in the Atlantic and Pacific regions (100). Most Colombians 
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(85%) report having an income just adequate to cover basic living expenses and 42% consider 




Fig. 1-1.  Map of Colombia 
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While the level of literacy in the country is high (94%) (101), there are regional differences. 
For example, illiteracy rates in Chocó and most of the departments located in the Atlantic coast 
are higher (>16%) than the rest of the Colombian departments (98).  
 
As a result of the historical exclusion of the rural population (102), the quality of life for 
people living in these areas of Colombia is poor. Inequities observed in rural areas have been 
influenced by a number of factors, such as the limited presence of the Colombian state in these 
territories, a scattered population, poor political representation, a lack of education and formal 
work opportunities (102), as well as limited access to services, like sanitation (103). Poverty 
rates in rural areas (44%) (103) are higher than urban areas, resulting in higher numbers of 
socially vulnerable people (104). Also, education is more limited in rural areas (104). Data from 
the 2014 Colombian Census of Agriculture, revealed that 20% of the population between 5 and 
16 years and 76% of individuals between 17 and 24 years living in rural areas were not enrolled 
in school (103).  
 
More than 40% of the Colombian population live in big cities, such as Bogotá, Medellín, Cali, 
Barranquilla, and Cartagena (94). In contrast, the departments located in the Amazon-Orinoquía 
region account for less than 3% of the total national population (94). Decisions made in the 
capital control policy (100) and the state has a very limited presence in the more remote 
Colombian territories (105). This fragile situation limits the efficacy and credibility of 
governmental institutions (105), creating the necessary conditions for groups, other than 
governmental agencies, to control certain areas of the country through corruption or violence 
(98).  
 
The Colombian internal armed conflict is one of the oldest of this kind in the world (106). 
Rooted in the 40s and 50s (107), this conflict has impacted the economic and social welfare of 
Colombian society. Homicides, kidnappings, injuries due to landmines, and forced displacements 
are some consequences of the conflict for the population (108). Given the length and intensity of 
the conflict, Colombia is ranked second as the country with the highest number of internally 
displaced persons worldwide (109). More than 6 million Colombians have been forced to leave 
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their homes (109) and have settled mainly in urban areas (94). The loss of individuals due to the 
conflict and the need to accommodate displaced individuals have had an impact on health and 
social services in Colombia (94).  
 
The internal conflict has impacted the quality of life and socioeconomic status of the 
displaced population (110). Children, women, and ethnic minorities are the most affected groups 
(108). Displaced children and adolescents suffer from infectious and malnutrition-associated 
diseases and lack access to vaccination programmes (108). Moreover, about 35% of displaced 
teenagers are mothers (108). Among the adult population, women are the most vulnerable group 
(108). Compared to the national distribution of women (51%), displaced women represent 54% 
of the total displaced persons (111). The proportion of displaced women between 25 and 49 
years is higher than the proportion of displaced males in the same age group (111). Displaced 
women are more likely to have lower literacy levels, a higher number of children, as well as 
more responsibilities at the family level due to being the household head (108). Other challenges 
to the wellbeing of displaced women include mental health issues, nutritional or gynaecological 
diseases, and a lack of access to health care (112). 
 
Barriers to accessing health care affect both displaced people and the rest of the Colombian 
population, with the greatest impact on the most disadvantaged groups (113-115). These barriers 
are related to a lack of specialised health care, long waiting lists, restrictions in accessing 
medical appointments and tests, out-of-pocket payments or co-payments, the suspension of 
health insurance coverage due to lack of payment, and the distance to health care centres (113). 
Furthermore, Colombians have to deal with escalating health care costs and poor quality of 
health services, as a consequence of a lack of regulation of the health care system and corruption 
(116).  
 
1.4.1. Health Care in Colombia 
The Colombian health care system is an insurance-based model system, known as the Sistema 
de Seguridad Social en Salud (SGSSS), that was established in 1993 by Law 100 (117). The 
model comprises the contributory and subsidised health insurances (118, 119) in which 
individuals are insured according to their capacity to pay (120). Formal employees and people 
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who can directly pay, as well as their beneficiary group, are affiliated to the contributory system 
(119). Individuals who cannot pay and are eligible for governmental benefits become part of the 
subsidised system (119). In addition to the beneficiaries of the SGSSS, there are special health 
care plans for individuals who belong to the military and police, as well as for public teachers 
and employees of the Colombian Oil Company (121).  
 
Despite achievements of the SGSSS related to increased numbers of Colombians with health 
insurance coverage (118) and improved access to free and population-based services (119), 
almost 10% of the population in 2012 did not have health care coverage (101). Furthermore, 
health care benefits differ between the subsidised and the contributory health systems. Compared 
to the contributory system, individuals in the subsidised system obtain up to 40% less health care 
benefits (118). This difference has created equity concerns, since formally employed individuals 
enjoy more benefits than people living with limited resources (120). In rural areas, limitations to 
access health services are common; in some cases, people living in rural areas opt to be treated 
using traditional medicine, given the difficulties in obtaining health services (122). Issues with 
authorisation for medical procedures or treatments, the control of clinical practice by health 
insurance companies, a fragmentation of services, a high turn-over of health care professionals, 
and a lack of clarity about services covered are examples of other barriers to access health care 
faced by Colombians (113). 
 
1.4.2. Cervical Cancer and HPV Infection in Colombia 
Cervical cancer is ranked as the second most common incident cancer among women in 
Colombia (123). Age-standardised incidence rates in Colombia (18.7 per 100,000) are higher 
than rates estimated for the Americas region as a whole (14.9 per 100,000) and countries such as 
Costa Rica (11.4 per 100,000), Chile (12.8 per 100,000), or Brazil (16.3 per 100,000) (9). 
Cervical cancer poses a high economic burden for Colombia, given the high direct costs 
associated with its treatment (124). Cancer of the cervix is one of the top ten most preventable 
causes of death in Colombia, accounting for 3% of the total economic costs associated with 
avoidable mortality (125). 
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Despite the reported decrease in mortality between 1984 and 2008 in Colombia (126), CC is 
the second cause of cancer deaths among women in the country (123). It was estimated that 
about five women died each day due to CC between 2000 and 2006 (127). Age-standardised 
mortality rates in Colombia (8 per 100,000) are higher than the Americas region and the rates 
estimated for Costa Rica, Chile, and Brazil (5.9 per 100,000, 4.4 per 100,000, 6 per 100,000, and 
7.3 per 100,000, respectively) (9). It has been suggested that late diagnosis and lack of access to 
treatment might explain 50% of CC deaths in Colombia (128). Inadequate or delayed access to 
CC treatment has been related to administrative formalities imposed by health insurance 
companies (129).  
 
Limited access to prevention programmes may be reflected in the distribution of the risk 
factors for CC, as shown in different Colombian reports. The 2010 National Demographic and 
Health Survey (NDHS) (122), a national representative survey, described that the median age of 
sexual onset reported by women aged 25-49 years was 18 years. However, this survey revealed 
that 11% of women reported being sexually active before they were 15 years of age and 48% 
started sexual intercourse before the age of 18. The NDHS also revealed that 17% of women 
aged 15-49 years did not have information about STIs other than HIV/AIDS (122), although 
most of the people seeking treatment for STIs in Colombia are women and individuals between 
20 and 29 years of age (130).  
 
A study that included women 15-69 years attending CC programmes from four regions of 
Colombia found that 49.6% were HPV positive and 64.8% of those who were positive had a co-
infection with multiple HPV types (131). A cohort study reported that during the follow-up 
period younger women and those with a new partner were more likely to be infected with high-
risk types of HPV (132). Another study found a higher odds of detecting high-risk HPV among 
women with a normal Pap test who were <35 years compared to women 35-44 years, as well as 
higher odds of detecting any type of HPV infection among those who reported two or more 
sexual partners compared to women who reported only one partner (133). Also, this study 
showed that women <30 years had higher odds of having infection by multiple HPV types 
compared to older women (133). Another study conducted in the Colombian capital found that 
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HPV infection affected more than 350,000 women, 54% of whom were <30 years (134). In 74% 
of the cases these infections were caused by high-risk HPV types (134).  
 
Having an infection by other sexually transmitted agent is also a co-factor for CC (6). A 
report on the distribution of STIs in Colombia between 2009-2011 showed that most Colombians 
who sought medical advice due to a STI were women and individuals aged 20-29 years (130). 
An international review reported an increased risk for CC among women infected by Chlamydia 
trachomatis and women with antibodies for herpes simplex virus type 2 (135). A recent study in 
various Colombian regions showed that women infected by multiple HPV types were also 
infected by Chlamydia trachomatis, especially among those who reported a greater number of 
sexual partners (136). A Brazilian study showed that women infected by gonorrhoea and 
Trichomona vaginalis had an increased risk for high grade cervical lesions (137).  
 
Given the increased risk for CC associated with other STIs, the reported data on the frequency 
of other STIs in women from Colombia were obtained and summarised. Data from the 
Colombian Ministry of Health show that Chlamydia trachomatis infection was most prevalent 
among Colombians aged 15-49 years (130). A 2003 study in Bogotá determined that 5% of 
women aged 18+ participating in the study were positive for C. trachomatis (138). Another study 
among female and male students between 14 and 19 years in a province of the department of 
Cundinamarca, showed that 2.2% of participants had a Chlamydia infection (139). In regards to 
herpes type 2, a multicentre study including Colombian women found that 57% of participants 
were seropositive to the virus (140). Additionally, gonorrhoea in Colombia is one of the most 
common STI, with more than 8,000 cases reported between 2009 and 2011 (130). The 
Colombian Ministry of Health also reported 6,200 cases of T. vaginalis, between 2009 and 2011 
(130). However, given a limited knowledge regarding STIs in Colombia (130), official rates of 
STIs could be affected by underreporting of cases.  
 
Decreasing the risk of HPV infection and increasing the chance that cervical lesions are 
detected before they become malignant require educational initiatives to improve awareness of 
HPV infection (25, 28). Despite the Colombian National Policy of Sexuality, Sexual, and 
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Reproductive Rights emphasises the need for sexual education (141), few programmes for 
education about sexuality have been implemented in the country (142).  
 
1.4.3. National Efforts to Prevent Cervical Cancer 
The National Programme for Cervical Cancer Control started in Colombia in 1990 with the 
objective of increasing screening rates and encouraging women to continue participating in the 
programme through follow-up and treatment (143). However, following Law 100, the 
programme became fragmented and dependent on health insurance companies (143). As a result, 
Colombian efforts to prevent CC are mainly centred in achieving a certain Pap test coverage 
instead of a programme offering appropriate treatment and follow-up to women with CC (144). 
Further complicating the issue of CC prevention in Colombia, leaders of both health services and 
health insurance companies lack information regarding the epidemiologic profiles for the 
populations they serve (129). This deficiency in information has been related to the lack of 
prioritisation of CC as a public health concern in Colombia (129), affecting the implementation 
of CC prevention programmes. 
 
Problems in the implementation of CC screening services in Colombia include inadequate 
training to interpret Pap tests, lack of infrastructure, difficulties for women to get to 
appointments, and lack of protocols to follow-up with women who have abnormal Pap tests 
(129). These problems exist in the context of a Colombian health care system which is centred 
primarily in curing rather than in preventing disease in the population (145). 
 
Recognising the limitations in existing CC programmes, Colombia, together with other 
countries in the Americas, agreed in 2008 to ensure prevention and control of CC through the 
Declaration of the Human Papilloma Virus Meeting held in Mexico (146). The Colombian 
government also agreed to reducing mortality rates from CC based on increasing screening 
coverage and guaranteed access of women to treatment, among other strategies (147). 
Furthermore, the government has launched the 2014-2018 National Development Plan (NDP), 
which aims to reduce the number of preventable deaths due to non-transmissible diseases, 
including cancer, guarantee sexual and reproductive rights, and increase the detection of CC 
(148). Given the emphasis in Colombia on treating rather than preventing disease occurrence 
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(145), the NDP proposes a change in this paradigm by increasing prevention as one of the pillars 
to reduce morbidity and mortality. Additionally, the Plan emphasises the importance of reducing 
social inequalities between urban and rural areas through ensuring equal opportunities for rural 
people (148).  
 
The importance of addressing these inequalities are outlined in the following sections 
examining inequities and challenges in primary prevention of CC, secondary prevention of CC, 
and mortality due to CC in Colombia. 
 
1.4.4. Inequities in Cervical Cancer in Colombia 
1.4.4.1.Inequities in primary prevention of cervical cancer 
Knowledge of HPV infection and of HPV vaccination has consistently been demonstrated as 
poor in Colombia (149-154). Between 34% and 72% of individuals participating in different 
Colombian studies have reported poor knowledge or no knowledge of HPV infection (149-151, 
154). A study among professors and students of a university located in the Central region (149), 
found significant variations in the knowledge of HPV according to the age of professors and the 
number of years that students had been in their university programme using Chi-square tests. No 
significant differences in the knowledge of HPV were found based on the type of health 
insurance of students. In contrast, other reports from Colombia have identified differences in 
HPV awareness by health insurance and education, using bivariate (154) and multivariable (151) 
analysis. Results of a descriptive study conducted in a Colombian university located in the 
Central region indicated that older students, women, and individuals with a better socioeconomic 
status were more likely to know about HPV (150).  
 
Other Colombian studies have found low levels of both knowledge of the relationship 
between CC and HPV infection (151, 152), and the association between CC and awareness of 
HPV vaccination (154). In a study conducted in Medellín, 86% of women 18+ years were 
unaware of the role of HPV in the development of CC (151). Another study among adolescent 
women in the city of Cartagena, located in the Atlantic region, reported 24% of women with 
knowledge of the link between HPV infection and CC (152). All participants in this study were 
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unfamiliar with preventing HPV infection through vaccination (152). Chi-square tests also 
showed no significant differences in the knowledge of HPV by type of health insurance and 
socioeconomic status (152). A study in Bogotá showed that only 26.4% of men and 48.4% of 
women were aware of the HPV vaccine (154). Based on Chi-square tests, this study also reported 
that having more education and contributory health insurance increased awareness of HPV 
vaccination (154). The problem of limited information about HPV extends also to health care 
professionals. A qualitative study among physicians from different specialities working in 
several cities of Colombia, showed that general practitioners exhibited lower levels of 
knowledge about the role of HPV on CC compared to gynaecologists and paediatricians (153). 
 
The results of the studies about inequities in primary CC prevention in Colombia reveal that 
efforts are needed in the country to educate the general population and health care professionals 
about HPV infection. Having adequate knowledge of HPV-related topics among health care 
practitioners is crucial, especially considering that they are a source of information about HPV 
and that they could promote HPV vaccination in the population (59). 
 
1.4.4.2.Inequities in secondary prevention of cervical cancer 
Socio-demographic factors in Colombia have also been linked to inequities in access to 
secondary prevention of CC. Although in 2005 more than 75% of women reported having had a 
Pap test in the previous three years (155), access to Pap testing in Colombia varied according to 
socio-demographic characteristics. For example, compared to older groups, younger women 
were less likely to participate in CC screening programmes (155-158). Living in rural areas has 
been suggested as another factor impacting CC screening in Colombia. The results of an 
unconditional analysis from a study that included women 16+ years from a rural municipality 
located in the Eastern region, reported that living in rural areas decreased the odds of having Pap 
testing (156). 
 
Education and access to health insurance have also been identified as risk factors limiting 
access to secondary prevention of CC. Other studies conducted in Colombia have found that, 
after controlling for other socio-demographic factors, women with less education have lower  
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odds of having a Pap test compared to women with higher levels of education (155, 157, 158). 
Furthermore, having a low socioeconomic status has been associated with decreased odds of 
having Pap testing. The results presented in the study of Piñeros et al (155) among women aged 
25-49 years showed that the odds of not having had a Pap test in the three previous years to the 
study decreased as the socioeconomic status of women increased. Moreover, having health 
insurance has been reported to increase access to CC screening (158), with differences according 
to the type of health insurance of women (155). 
 
1.4.4.3.Inequities in mortality due to cervical cancer 
In addition to the inequities described for primary and secondary prevention of CC, inequities 
in CC mortality have also been reported in Colombia. For example, differences in CC mortality 
rates among departments have been identified. Higher age-adjusted CC mortality rates were 
reported in the Colombian departments of Meta, Tolima, Arauca, and Caquetá from 2000 to 
2006 (127). These results coincide with another study analysing CC mortality data of women 
aged 15+ years in the period 2005-2008, which found the highest mortality rates in the 
departments of Arauca, Meta, Tolima, Caquetá, and Quindío (159). The results of this study also 
suggested that CC mortality rates were higher in urban than in rural areas (159). In contrast, 
Chocontá-Piraquive et al (160) reported high CC mortality rates between 2000 and 2004 among 
women of all ages in the departments of Caldas, Tolima, Quindío, and Risaralda.  
 
Socioeconomic status has also been suggested as an important predictor of CC mortality in 
Colombia. An ecological study using 2000-2007 mortality data from women of all ages in the 
department of Antioquia, located in the Central region of Colombia, showed an association 
between CC mortality rates and social variables in the department, such as poverty, illiteracy, 
and unmet basic needs (161). High levels of poverty and unmet needs were related to higher 
mortality rates due to CC; in contrast, lower levels of illiteracy were associated with lower CC 
mortality rates (161).  
 
Again, similar to the observations for primary and secondary prevention of CC, education and 
insurance have been suggested as important risk factors CC mortality in Colombia. A recent 
Colombian study about mortality and educational level among women between 25 and 64 years 
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who died from CC, found that women with primary and secondary education had an increased 
risk of dying due to CC compared to women with higher education (162). In relation to health 
insurance, one study reported an association between the proportion of uninsured women and 
mortality rates, finding higher mortality rates when the proportion of women with no health 
insurance increased (160). Furthermore, this study showed that CC mortality decreased about 




The rationale for investigating factors associated with the primary and secondary prevention 
of CC and mortality due to CC in Colombia in this thesis included access to national data that 
provided a unique opportunity to build on previous research that could lead to reducing 
inequities in health.  
 
The results presented in this thesis are based on data from the 2010 NDHS, a nationwide and 
representative household survey (122), as well as the Colombian official mortality records. The 
2010 NDHS assessed different aspects of women’s health and their households collected to 
guide policy (122). In the 2010 NDHS, women were asked, among other topics, about HPV, CC 
prevention, and associated risk factors (122). Official mortality records from 2005 to 2013 were 
obtained from the Colombian National Administrative Department of Statistics (Departamento 
Administrativo Nacional de Estadística - DANE). The Colombian DANE has been gathering, 
processing, analysing, and disseminating statistical information for about 60 years (163), 
including the collection of mortality data at the national level.  
 
Colombia is one of the most inequitable countries in Latin America (96). Colombians have to 
deal with high levels of inequity in the distribution of the SDOH, such as income (97-101) and 
education (98, 103, 104). Also, the country has experienced a long internal armed conflict, with 
millions of displaced individuals, who are primarily women (111). In this social context, CC is 
ranked as the second most common incident cancer and the second most common cause of 
cancer deaths among Colombian women (123), affecting a large number of women and their 
families. Added to these problems, health inequities have grown in Colombia after the 
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implementation of a health system that provides inequitable care for the poor compared to the 
wealthy (120).  
 
Although inequities in primary (149-154) and secondary CC prevention (155-158), as well as 
inequities in CC mortality (127, 159-162) have been reported in Colombia, nationwide studies 
evaluating how socio-demographic factors relate to primary and secondary prevention of CC and 
CC mortality specifically in young Colombian women are lacking in the country.  
 
There are many opportunities to build on the existing literature regarding knowledge of HPV 
and primary CC prevention strategies. Previous Colombian reports have not focused explicitly 
on young women and the results of analyses are sometimes limited based on the number and type 
of variables examined and the comprehensiveness of statistical analysis conducted. To date, there 
are no nationwide studies evaluating multiple factors associated with awareness of HPV 
vaccination among young women in Colombia. For example, studies assessing knowledge of 
HPV or HPV vaccination have included both males and females or females only of various age 
ranges living in several Colombian cities (149-154). Also, most of these studies used descriptive 
(150), bivariate (149, 152) or qualitative analysis (153). Two studies that assessed knowledge of 
HPV, measured the role of type of health insurance using simple bivariate analysis (149) and 
descriptive statistics (152). One study conducted in the city of Medellín to assess the knowledge 
of HPV among women aged 18-69 years included age and education as the independent 
variables of interest (151). Results of another study conducted in Bogotá that measured 
awareness of HPV and HPV vaccine, stated that a multivariable model was tested to assess 
confounding; however, the results of this analysis were not included in the published version of 
the study (154).  
 
There are similar opportunities to build on the existing understanding of factors influencing 
secondary prevention strategies. In relation to Pap testing, although access to CC screening 
among women has been reported to be good in Colombia (155), there are no studies assessing 
the socio-demographic factors associated with Pap testing taking into account the effect of the 
context where women live (e.g. neighbourhood) on the probability to access this test. Most of the 
studies available have been conducted among women aged 13+ years living in specific cities 
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(155-158). There are limitations in the two studies investigating the role of health insurance in 
Pap testing (155, 158). The authors of the only nationwide study used a simple logistic 
regression to assess the effect of health insurance on the probability of having a recent Pap test 
among women 25-49 (155). Women aged 18-24 years were not included in this study, and 
contextual effects were not assessed. The study of Lucumí Cuesta et al (158) conducted in 
Bogotá considered affiliation status of women as a dichotomous variable without specifying the 
type of insurance.  
 
Furthermore, spatial variations in accessing primary and secondary CC preventing strategies 
have not been examined among young women, despite the diversity in socio-demographic 
factors among Colombian departments. The application of tests for global and local clustering 
could be useful to the detect a lack of randomness in the spatial distribution in the outcome 
variables of interest (164, 165). Furthermore, modelling of spatial data could be helpful to 
evaluate factors related to the spatial variability in the access to primary and secondary CC 
prevention in Colombia beyond that explained by fixed effects, such as education and insurance 
(164, 165). These kinds of analyses could help examine geographical differences in risk of 
accessing CC prevention and identify areas where further study is needed to best optimize the 
use of limited resources for CC prevention.  
 
Regarding mortality, previous studies evaluating factors associated with CC mortality have 
focused on a broad range of ages (159-162). Results of these studies do not provide explicit 
evidence on how socio-demographic factors are associated with premature CC mortality in 
young women. Similarly, no studies to date have examined factors associated with variations in 
mortality rates by assessing interactions between other risk factors and age. In relation to risk 
factors and mortality, the study of de Vries et al (162) assessed the relevance of education in CC 
mortality among women aged 25-64 years; however, women with no formal education were not 
included in the analysis. Women with no education were included in a study by Baena et al (161) 
that evaluated variations in CC mortality rates according to percentage of literacy in a specific 
department of Colombia. There is only one previous study that evaluated the role of health 
insurance in CC in Colombia (160). This study did so by evaluating the association between the 
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percentage of uninsured women and CC mortality rates and, therefore, did not include 
comparisons among different types of health insurance. 
 
Moreover, considering the limitations to access health care faced by women living in rural 
areas of Colombia (122), only one study included rural residence as a risk factor for having Pap 
testing in a multivariable regression analysis (156). However, this study was limited to a 
municipality located in the department of Santander. Similarly, despite the diversity of 
Colombian regions (98), just two studies have reported the distribution of Pap testing (155) and 
CC mortality rates (127) by departments. There are no nationwide studies conducted in 
Colombia showing associations between either Pap testing or CC mortality and both rural 
residence and region or department of residence. 
 
1.6. Goals and Objectives of This Research 
The goals of this thesis are to identify individual and department socio-demographic 
characteristics associated with awareness of primary prevention programmes and access to 
secondary prevention programmes for CC in Colombia. The goals of this thesis also include 
examining the relationships among socio-demographic factors in young Colombian women and 
CC mortality.  
 
The specific questions that guided this research were as follows: 
a. What socio-demographic factors are associated with having heard about HPV 
vaccination among women between 13 and 49 years in Colombia? 
b. What socio-demographic characteristics of women aged 18 to 49 years in Colombia 
are associated with having ever had a Pap test? 
c. Is there a spatial pattern in the department frequencies of women not having heard of 
HPV vaccination and the department frequencies of not having had Pap testing that 
could be explained by variations in socio-demographic factors in Colombia? 
d. Are there differences in CC mortality rates of women aged 20 to 49 years in Colombia 
associated with their socio-demographic factors? 
 
To answer each of the questions, this thesis has been organised into a series of four chapters.  
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Article 1, presented in Chapter 2, used data from the 2010 NDHS. Using a multivariable 
logistic regression model, this paper examined differences in the socio-demographic factors 
associated with the probability of having heard of HPV vaccination among women aged 13-49 
years. 
 
Article 2, presented in Chapter 3, also used data from the 2010 NDHS. The goal of this paper 
was to identify the socio-demographic factors related to ever having had a Pap test among 
women aged 18 to 49 years. Using a generalised linear mixed model, this article also explored 
the influence that neighbourhood and municipality where women live had on the probability of 
having had Pap testing. 
 
Article 3, presented in Chapter 4, used data from both the 2010 NDHS and the DANE. Global 
and local tests for detecting clustering, as well as Bayesian Poisson hierarchical models were 
used to identify spatial patterns in having heard of HPV vaccination and not ever having had a 
Pap test, as well as department factors associated with the outcomes of interest. 
 
Article 4, presented in Chapter 5, used CC mortality records from 2005 to 2013 and 
population projection data made available by DANE. The study also made use of the 2010 
NDHS to characterise the population at risk. Associations between socio-demographic factors 
and mortality due to CC were explored using multivariable negative binomial regression models. 
 
The papers presented in Chapters 2 to 5 have been previously published in peer-reviewed 
journals. Full citations are given at the beginning of each chapter. The permissions to include the 
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CHAPTER 2 – PREDICTORS OF HAVING HEARD ABOUT HUMAN PAPILLOMAVIRUS 
VACCINATION: CRITICAL ASPECTS FOR CERVICAL CANCER PREVENTION AMONG 
COLOMBIAN WOMEN 
Article reproduced with minor edits and with permission. Originally published as: “Bermedo‐
Carrasco S, Feng CX, Peña‐Sánchez JN, Lepnurm R. Predictors of having heard about human 
papillomavirus vaccination: critical aspects for cervical cancer prevention among Colombian 
women. Gac Sanit. 2015;29:112-7. http://dx.doi.org/10.1016/j.gaceta.2014.09.005.” My 
contributions to this study included the study design, data acquisition and analysis, interpretation 




This chapter describes risk factors associated with having heard about the human 
papillomavirus (HPV) vaccine among young Colombian women, including socio-demographic 
factors, such as age, educational level, socioeconomic and working status, type of health 
insurance, having rural or urban residence, and region of residence. This is the first nationwide 
study in Colombia among women aged 13-49 years examining socio-demographic factors 
associated with a primary prevention strategy for cervical cancer (CC). In addition to the 
identified low prevalence of HPV vaccination awareness, this work demonstrates the presence of 
inequities and a social gradient in CC primary prevention, showing a key role of education and 
rural residence. The study results could guide the development of CC prevention programmes to 





Cervical cancer (CC) is responsible for over 275,000 female deaths each year, with more than 
500,000 new cases diagnosed worldwide (1). Persistent infection of the anogenital tract with 
high-risk human papillomavirus (HPV), which is a sexually transmitted disease (2), has been 
established as a necessary cause for cervical intraepithelial neoplasia and CC (3, 4). Factors such 
as being sexually active, young age, oral contraceptive use, socioeconomic status, high parity, 
smoking status, and previous HPV infections, among others, have been associated with the 
transmission of HPV (2). 
Vaccination against certain high-risk HPV types among women without previous exposure to 
these viruses and ideally before their sexual debut has been associated with a reduction of pre-
invasive cervical lesions (2, 5). HPV vaccination provides a potential cost-effective way to 
prevent CC (6). Currently, two vaccines are available against HPV: the bivalent vaccine protects 
against HPV types 16 and 18; the quadrivalent one protects against HPV types 6, 11, 16, and 18 
(5). Awareness of prevention of CC is key to support HPV vaccination (7) and raising 
knowledge about the role of HPV in the development of CC is central in CC prevention (8). 
Previous studies have shown that a low intention of HPV vaccination is associated with limited 
awareness and poor knowledge of HPV vaccination (7, 9, 10). Therefore, measuring awareness 
of HPV vaccination is critical for CC prevention programmes. 
In Colombia, CC is the cancer most frequently affecting women (11, 12). It has been 
estimated that about 15% of Colombian women will develop a HPV infection during their 
lifetime (12). The Colombian Instituto Nacional de Vigilancia de Medicamentos y Alimentos 
(INVIMA) approved the quadrivalent and bivalent HPV vaccines in 2006 and 2007, respectively 
(13); then, the HPV vaccines were available for women who were willing to pay for them. The 
quadrivalent HPV vaccine is an insured service for girls aged 9 years and older since 2012 (14). 
However, a lack of knowledge about HPV infection and HPV vaccination has been reported in 
Colombia, especially among less educated and low income groups (8, 15). Indeed, these 
disadvantaged groups have been highly affected by the structure of the Colombian Sistema 
General de Seguridad Social en Salud (SGSSS), which is an insurance-based health care system 
(16). This system has increased barriers to access health care (16) and obtain equal health 
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benefits for individuals unable to pay (subsidised health insurance) (16, 17) compared to those 
who can contribute to the system (contributory health insurance) (16, 18) and those who belong 
to groups with special health care plans (public teachers, workers of public universities, military 
forces, police, and employees of the Colombian Oil Company) (19). 
To the best of our knowledge, there are no nationwide studies in Colombia evaluating 
socioeconomic and personal factors associated with having heard about HPV vaccination among 
women. Therefore, our objectives were to determine: (1) the prevalence of Colombian women 
having heard about HPV vaccination; (2) whether the probability of having heard about HPV 
vaccination differs by age group, educational level, socioeconomic (wealth quintile) and working 
status, type of health insurance, region and rural/urban area of residence, women having 
experienced intercourse, type of contraceptive method used, and women who have had children; 
and (3) whether the effect of predictors for having heard about HPV vaccination differs at 
different educational levels and rural/urban area of residence. 
2.2. Methods 
The data were drawn from the 2010 National Demographic and Health Survey (NDHS), a 
national representative survey conducted among women between 13 and 49 years old living in 
Colombia. In total, 53,521 out of 56,886 women participated in the NDHS (response rate = 94%) 
(20). This survey evaluated socio-demographic characteristics of participants, as well as different 
aspects of their health. 
All women were asked whether they had heard about the HPV and also if they had ever heard 
about a vaccine to prevent CC. Women who reported having heard about HPV and having heard 
about a vaccine to prevent CC were classified as “1 = have heard about HPV vaccination;” 
otherwise, they were classified as “0 = have not heard about HPV vaccination.” This was the 
dependent variable of our study. Self-reported factors considered as independent variables in the 
study were age group, educational level, wealth quintile, working status, type of health 
insurance, having experienced intercourse, type of contraceptive method used, having children, 
and region and rural/urban area of residence. Atlantic, Amazon-Orinoquía, Central, Eastern, and 
Pacific were the regions established in the Colombian NHDS; Bogotá (the capital) was included 
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in the Eastern region. Chi-square tests were performed to test differences in the distribution of 
women in different categories of the independent variables. 
 
A logistic regression model was built using the manual backward method at a 5% level of 
significance. Variables not included in the model were tested as confounders; the presence of 
confounding was considered if these variables changed the parameter estimates of predictors in 
the model by more than 10%. Additionally, educational level and rural/urban area of residence 
were tested as modifier effects. 
 
Unadjusted (UORs) and adjusted odds ratios (AORs), 95% confidence intervals (95%CIs), 
and p-values were computed. Women with missing data were excluded from the multivariable 
analysis. Model diagnostics were examined through receiver-operating characteristic (ROC) 
curves and assessment of residuals. The analyses were performed using SAS software version 
9.3 (SAS Institute Inc., Cary, NC, USA). 
 
The Ethical Committee of the Asociación Probienestar de la Familia Colombiana 
(Profamilia) provided ethical approval for the 2010 NDHS; participants gave their consent before 
the administration of the survey. To use the 2010 NDHS data for the present study, the 
University of Saskatchewan Research Ethics Board provided an exception for ethics review. 
 
2.3. Results 
In total, data from 53,521 women aged 13–49 years were obtained. The mean age of the 
women was 29.2 years (SD=10.8). The distribution of women's characteristics is presented in 
Table 2-1. Of the total women, 14,363 (26.8%; 95%CI=26.3–27.1%) reported having heard 
about HPV vaccination. The proportion of women who heard about HPV vaccination by age 
group was: 13–18 years, 12.9% (95%CI=11.4–14.4%); 19–24 years, 16.6% (95%CI=15.1–
18.1%); 25–32 years, 23.9% (95%CI=22.5–25.3%); 33–40 years, 21.7% (95%CI=20.3–23.1%); 
and 41–49 years, 24.9% (95%CI=23.5–26.3%). Among the 14,363 women who have heard 
about HPV vaccination, 49% had secondary education, 23.9% belonged to the highest wealth 
quintile, 83.8% were working, 50.7% had contributory health insurance, 84.2% were living in 
urban areas, 27.4% lived in the Eastern region, 88% had experienced intercourse, 38.7% were 
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not using contraceptive methods, and 67.4% had children. Statistically significant differences 
were found when comparing socio-demographic and sexual factors among women who had 
heard about HPV vaccination and those who had not. Bivariate analyses indicated that all the 
predictors were significantly associated with the dependent variable (p-values<0.001); UORs and 
their 95%CI are shown in Table 2-1. 
 
Table 2-1.  Descriptive statistics for variables used in the model building, unadjusted odds 
ratios (UOR) and corresponding 95% confidence intervals (CI). National Demographic and 






































































































































































































































































































a n (%). 
b Some percentages with rounding error.  
 
In the model building, age was found to be not linearly related to the log odds of the outcome 
(p<0.001); therefore, it was included as a five-category variable which was created according to 
age distribution. Working status and having experienced intercourse were variables initially 
removed from the model (p-values>0.05); notwithstanding, working status was found to be a 
confounding variable and was included as a covariate in the model. Also, significant interactions 
were found between educational level and age group (p=0.002), educational level and region (p< 
0.001), and rural/urban area of residence and region (p<0.001). 
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Table 2-2 presents AORs and their corresponding 95% CIs of predictors not interacting in the 
logistic regression model. Regarding wealth quintile, women in the lowest (AOR=0.44; 
95%CI=0.40–0.49) and lower (AOR=0.57; 95%CI=0.53–0.61) quintiles were less likely to have 
heard about HPV vaccination in comparison to women from the highest quintile. Similarly, 
women in the middle (AOR=0.64; 95%CI=0.59–0.68) and higher (AOR=0.74; 95%CI=0.69–
0.79) wealth quintiles were less likely to have heard about HPV vaccination. The type of health 
insurance was also significantly associated with having heard about HPV vaccination. Women 
with subsidised health insurance (AOR=0.69; 95%CI=0.66–0.73) and those non-affiliated to any 
health insurance (AOR=0.73; 95%CI=0.68–0.79) were less likely to have heard about HPV 
vaccination than women in the contributory group. Women using condoms (AOR=1.19; 
95%CI=1.10–1.29), hormonal methods (AOR=1.20; 95%CI=1.13–1.28), or who were sterilised 
(AOR=1.10; 95%CI=1.03–1.17) were more likely to have heard about HPV vaccination than 
those not using any contraceptive method. Furthermore, women with children were less likely to 
have heard about HPV vaccination compared to women with no children (AOR=0.87; 
95%CI=0.81–0.92). 
 
Table 2-2.  Adjusted odds ratio (AORs) and corresponding 95% confidence intervals (CI) of 
having heard about human papillomavirus vaccination by non-interacting predictors (n=53,520). 
National Demographic and Health Survey (NDHS) Colombia, 2010.  
Predictor Categories AOR (95%CI) 
Wealth quintile Lowest 0.44 (0.40–0.49)  
Lower 0.57 (0.53–0.61)  
Middle 0.64 (0.59–0.68)  
Higher 0.74 (0.69–0.79)  
Highest Ref. 
Working No 1.05 (0.98–1.12)  
Yes Ref. 
Type of health insurance Non-affiliated 0.73 (0.68–0.79)  
Subsidised 0.69 (0.66–0.73)  
Special 0.91 (0.81–1.02)  
Contributory Ref. 
Contraceptive method Condoms 1.19 (1.10–1.29)  
Hormonal methods 1.20 (1.13–1.28)  
Female sterilisation 1.10 (1.03–1.17)  
Other methods 1.05 (0.97–1.13)  
Not using Ref. 
Have had children Yes 0.87 (0.81–0.92)  
No Ref. 
 
Predictors interacting in the model are depicted in Fig. 2-1, Fig. 2-2 and Fig. 2-3. The 
probabilities of having heard about HPV vaccination were higher among older age groups and 
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women with better levels of education; however, differences in these probabilities by age group 
were more evident among educated women compared to non-educated ones (Fig. 2-1). 
Comparing the level of education by region (Fig. 2-2), it was observed that women with no 
education had the lowest probabilities of having heard about HPV vaccination in all regions, and 
that the probability gap between these women and the highly educated ones was wider in the 
Eastern than in the Amazon-Orinoquía region. Also, among women with high educational levels, 
those living in the Amazon-Orinoquía region had the lowest probability of having heard about 
HPV vaccination; however, highly educated women of the Amazon-Orinoquía region were more 
likely to have heard about vaccination than those with lower levels of education in any other 
region. Furthermore, women living in rural areas had lower probabilities of having heard about 
HPV than those living in urban areas (Fig. 2-3); notwithstanding, women living in urban areas of 
the Amazon-Orinoquía region had similar probabilities than those living in rural areas of the 
Eastern region. Also, narrower gaps between women in rural and urban areas were observed in 
the Atlantic and Amazon-Orinoquía regions. 
 
 
Fig. 2-1. Predicted probabilities and 95%CIs of having heard about HPV vaccination by age 
group and educational level; NDHS Colombia, 2010. 
 45 
 
Fig. 2-2. Predicted probabilities and 95%CIs of having heard about HPV vaccination by region 
of residence and educational level; NDHS Colombia, 2010. 
 
 
Fig. 2-3. Predicted probabilities and 95%CIs of having heard about HPV vaccination by region 
and rural/urban area of residence; NDHS Colombia, 2010. 
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In the model diagnostics, the ROC curve showed that the logistic model correctly classified 
72.5% of the women who had heard about HPV vaccination, which could be considered as 
satisfactory. Also, the assessment of residuals showed that they were within an adequate range of 
±3 standard deviations from zero. 
 
2.4. Discussion 
The low prevalence of women who had heard about HPV vaccination found in our results is 
in accordance with a previous study claiming a poor awareness of HPV vaccination among 
adolescents in Cartagena, Colombia (21). This lack of awareness of HPV vaccination in the 
country could be resulting from poor national “HPV educational efforts (8).” Other authors in 
Colombia have reported a higher proportion of individuals aware of HPV and HPV vaccination 
(8, 15); however, their samples included patients attending health care centres. The participants 
of these studies could have more access to HPV-related information which could increase their 
level of HPV awareness. Also, these studies did not include women below 18 years and data 
were drawn from larger cities, such as Medellín (8) and Bogotá (15). Our study included not only 
nationwide data of women aged 18–49 years but also incorporated data of women from 13 to 17 
years which represented 18.2% of the total sample. We identified that women in the youngest 
age group had the lowest prevalence of having heard about HPV vaccination. Studies in other 
countries have reported higher awareness of HPV vaccination (22, 23). A recent study in 
developed countries identified that more than 80% of women had heard about HPV vaccination 
(23); in contrast, after a mass media advertisement campaign to promote HPV vaccination in 
Argentina, 36% of the women had an adequate knowledge about HPV vaccination (22). 
 
Different studies have considered the existence of variations in the level of awareness of HPV 
vaccination by socioeconomic (8, 15, 21-25) and educational status (7-10, 15, 22, 24, 25). We 
identified that the prevalence of having heard about HPV vaccination was low among women 
who belonged to deprived socioeconomic levels, non-insured individuals, and women covered 
by the subsidised health insurance. These findings are in agreement with other studies showing 
socioeconomic disparities in knowledge of HPV vaccination in Colombia (8, 15, 21). A study 
conducted among individuals with genital warts in Bogotá identified that participants without 
health insurance coverage, and beneficiaries of the subsidised health insurance were less aware 
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of HPV vaccination (15). In fact, individuals in the subsidised health insurance receive about 
40% less health benefits than those in the contributory one (18), and most of the non-insured 
people belong to the lowest income group (17). Therefore, barriers to access health care 
experienced by disadvantaged groups in Colombia could be affecting knowledge about HPV and 
HPV vaccination, since health care professionals are an important source of information about 
HPV vaccination and a motivating factor for HPV vaccine intake (9, 10, 22, 24, 26). 
 
Our results show novel information regarding modifier effects of education and rural/urban 
residence on the awareness of HPV vaccination. In Colombia, researchers have identified that 
individuals living in rural areas are more likely to report a poor health status (27), and that these 
individuals are highly impacted by economic, political, and social problems of the country 
compared to people living in urban areas (28). Furthermore, low educational levels and high 
poverty indicators have been reported in departments located in the Amazon-Orinoquía, Pacific, 
and Atlantic regions (29). These findings agree with our results that show low probabilities of 
having heard about HPV vaccination among women living in these three regions of Colombia, 
specifically if they have rural residence and low educational levels. Thus, there is a need to 
reduce these gaps when designing and implementing educational initiatives about HPV 
vaccination. Further programmes educating the general population about CC and its relation to 
HPV are critical to increase knowledge about HPV vaccination (8, 9, 15, 30). 
 
Although it is known the role that parents have in approving participation of their daughters in 
HPV vaccination programmes (7, 9, 25, 31, 32), we identified that women with children were 
less likely to have heard about HPV vaccination compared to women with no children, adjusting 
by age and other factors. This lack of awareness suggests that parents could be experiencing 
limitations to obtain information about HPV vaccination. A qualitative study conducted in four 
Colombian regions showed that parents were unaware of HPV vaccination and that receiving 
information was central to decide vaccinating their daughters (31). Additionally, it needs to be 
recognised that the socioeconomic context of parents impacts on their ability to support HPV 
vaccination of their family members (25, 31). Given that discussions about HPV vaccination 
between parents and children are a starting point to approach sexuality issues (31, 32), 
continuous efforts to educate about CC prevention and HPV vaccination are definitely needed 
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not only for young women (10, 30) but also for older populations (i.e., parents and grandparents). 
Women need multiple sources of information about HPV vaccination, including the advice that 
they could receive from other women they trust (30). 
 
We propose that CC prevention and education programmes recognise and overcome existing 
inequities – “inequalities considered unfair or stemming from some form of injustice (33)”– in 
the awareness of HPV vaccination. Therefore, national and local campaigns should be 
encouraged to change the paradigm of insufficient commitment to improve prevention and health 
promotion programmes within the Colombian SGSSS (19). These campaigns should ensure the 
reception of educational messages about HPV vaccination in the general population, 
emphasizing socially disadvantaged groups (22, 24, 25). Furthermore, working with health care 
professionals, schools, and community organisations might help develop better health promotion 
and preventive strategies to overcome difficulties related to area and region of residence, 
educational level, and health insurance coverage. We also recommend studies that evaluate 
successful experiences about HPV vaccination awareness and CC prevention campaigns to 
adjust and replicate them across the country. These studies should also include an assessment of 
the knowledge about HPV infection and HPV vaccination using validated instruments (23, 34). 
Given that HPV vaccination is an insured service and that the Colombian Ministry of Health is 
leading CC prevention strategies (14), awareness of HPV vaccination in upcoming studies could 
be compared to our results to explore persistence of inequities. 
 
Limitations of this study are primarily due to its cross-sectional design, which only provides 
information about associations. In addition, our study evaluated whether women had heard about 
HPV and a vaccine to prevent CC, which could be considered as a proxy of HPV vaccination 
knowledge. Also, it needs to be acknowledged that social desirability could have an impact on 
the findings. 
 
In conclusion, almost three quarters of the women in Colombia had not heard about HPV 
vaccination. The socio-demographic variations found on having heard about HPV vaccination 
indicate the presence of inequities and a social gradient in the awareness of HPV vaccination in 
Colombia. These findings suggest that programmes raising awareness of vaccination to prevent 
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CC have had a poor impact and that they could be neglecting marginalised groups of women in 
Colombia. Hence, further educational programmes about CC prevention and HPV vaccination 
should target the general population, although specific strategies are also necessary to reach 
disadvantaged groups (low socioeconomic strata, individuals with subsidised health insurance, 
women with no education, and those living in isolated or rural regions). 
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CHAPTER 3 – INEQUITIES IN CERVICAL CANCER SCREENING AMONG COLOMBIAN 
WOMEN: A MULTILEVEL ANALYSIS OF A NATIONWIDE SURVEY 
Article reproduced with minor edits and with permission. Originally published as: “Bermedo‐
Carrasco S, Peña‐Sánchez JN, Lepnurm R, Szafron M, Waldner C. Inequities in cervical cancer 
screening among Colombian women: a multilevel analysis of a nationwide survey. Cancer 
Epidemiol. 2015; 39:229-36. http://dx.doi.org/10.1016/j.canep.2015.01.011.” My contributions 
to this study included the study design, data acquisition and analysis, interpretation of the results, 




This chapter builds on the inequities in primary cervical cancer (CC) prevention identified 
among Colombian women in Chapter 2 by describing socio-demographic risk factors for whether 
or not women aged 18 to 49 years have ever had Pap testing. Age, educational level, 
socioeconomic and working status, type of health insurance, having a rural or urban residence, 
region of residence, having children, and whether women make their own health care decisions 
were factors associated with having a Pap test. This study is the first in Colombia showing that a 
lack of education in the neighbourhood where women live was also an important factor 
associated with Pap test uptake, demonstrating that CC screening decreased as the prevalence of 
no education in neighbourhoods increased. The evidence presented in this chapter highlights that 
CC screening programmes should acknowledge not only individual socio-demographic 
attributes, but also the importance of education in all women who live nearby and may contribute 







Although cervical cancer (CC) is considered a preventable disease (1, 2), worldwide it is 
ranked third for incident cancer cases and fourth for cancer-related mortality (3-5). In South 
America, CC is the second most incident cancer and first for cancer mortality among women 
between 15 and 44 years (5). In Colombia, CC is the second most common cancer (6) and has a 
proportional mortality of 12%, making it the second most common cause of cancer mortality (7). 
 
The Pap smear, or Pap test, is used globally to screen for pre-cancerous lesions of the cervix 
(8). Hence, failure to have a Pap test has been considered a risk factor for CC (9). The 
Colombian recommendations for CC screening state that women between 25 and 69 years (or 
younger who have experienced intercourse) should have free access to Pap testing; however, a 
Colombian committee of experts advised starting CC screening at 21 years of age (10). The 
recommended frequency of Pap testing in Colombia is 1-1-3 which means if two consecutive 
annual tests are negative, subsequent tests should be repeated every third year (10). In spite of 
these recommendations, Pap test coverage in Colombia is lower than in other Latin American 
countries (11). Furthermore, the CC screening programme is decentralised in Colombia; health 
insurance companies and their network of health care providers are responsible for Pap testing 
(12). 
 
Studies conducted in Colombia have identified differences in access to Pap testing between 
rural and urban areas and among geographic region of residence (13, 14), educational level (15), 
wealth quintile (15), age group (15, 16), and type of health insurance (16). Colombia has an 
insurance-based health care system, the Sistema General de Seguridad Social en Salud (SGSSS – 
the General Social Security System in Health), with two schemes: contributory and subsidised 
(17). Workers and retired individuals with the ability to pay belong to the contributory system, 
and those unable to pay are part of the subsidised system (17, 18). Public teachers and 
universities workers, members of the military forces, police, and employees of the Colombian 
Oil Company have special health insurance plans (18). Differences in access to health care 
benefits between the contributory and subsidised systems have been reported (19-21) which 
mainly affect disadvantaged populations (19, 22, 23). The SGSSS has been criticised for not 
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considering geographical, social, and cultural contexts, increasing barriers to access health care 
(24). 
 
While residential context influences participation in Pap testing (25), previous studies 
exploring factors affecting Pap test uptake in Colombia (13, 15) have not considered the 
influence of contextual factors on the probability of having a Pap test. The aim of this study was 
to identify socio-demographic factors related to ever having had a Pap test among sexually active 
women aged 18–49 years in Colombia, considering the influence of neighbourhood and 
municipality where women live. The specific objectives of this study were to identify factors 
associated with whether women in Colombia have had a Pap test, evaluate differences in risk 
factors between rural and urban residence, and evaluate the contextual effect of the lack of 
education on having had a Pap test. 
 
3.2. Material and Methods 
3.2.1. Study Population and Data 
Data for this study were part of the 2010 National Demographic and Health Survey (NDHS), 
a Colombian nationwide survey assessing different aspects of women's health. The NDHS 
included information from 53,521 women aged 13–49 years representing 51,447 households 
(13). The data were collected using random, cluster, and multistage sampling. Households were 
grouped with others of similar characteristics and proximity, creating groups of houses 
(hereinafter called neighbourhoods) with an average of ten households. The NDHS subdivided 
Colombia into five geographic regions (Amazon-Orinoquía, Pacific, Central, Atlantic, and 
Eastern). 
 
In the NDHS, only women 18 years or older, who had not had a hysterectomy, and who had 
experienced intercourse, were eligible to answer questions about CC prevention. Consequently, 
this work is based on the responses of the 40,410 (out of the original 53,521) women who met 
this eligibility criterion for answering questions related to CC screening (Pap test). Women, who 
self-declared they had heard about Pap smears and have ever had a Pap test, were classified as “1 
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= have had a Pap test”; otherwise, they were classified as “0 = have not had a Pap test.” This was 
the outcome variable of interest for this study. 
The Ethical Committee of the Asociación Probienestar de la Familia Colombiana 
(Profamilia) provided ethical approval prior to data collection. Also, Profamilia obtained consent 
from participants before the administration of the NDHS. To conduct the present analysis using 
the 2010 NDHS database, the University of Saskatchewan Research Ethics exempted the project. 
3.2.2. Statistical Analysis 
The frequencies of women who had a Pap test were calculated according to socio-
demographic factors of interest, including age, whether women had children, whether they had 
the final say on their own health (who makes decisions related to the woman's health), 
educational level, wealth quintile, working status, rural/urban area of residence, region of 
residence, and type of health insurance (Table 3-1). Considering the sampling procedure and the 
resulting hierarchical structure of the data (Fig. 3-1), a three-level mixed model (first level: 
women, second level: neighbourhoods, and third level: municipalities) for a binomial outcome 
with a logit link function and Laplacian approximation was used. The errors for the second and 
third levels were considered as random effects to account for variation in the probability that 
women would have a Pap test among municipalities and neighbourhoods. Multilevel modelling 
has the advantage of examining how both group and individual factors impact the outcome 
variable (26), considering the potential clustering of outcomes within groups (27). This technique 
also allows an exploration of the potential contextual effects of group membership (28). The 
average number of observations and proportion of replications per level were examined for each 
of these random intercepts. The geographic region (group of departments) was considered as a 
predictor in the fixed portion of the model. 
57 
Table 3-1.  Distribution of women who have and have not had a Pap test by socio-demographic 
factors and unadjusted odds ratios (UOR) with corresponding 95%CI computed in a three-level 
logistic model (n = 40,392). 
All women (n = 40,410) Have had a Pap test a UOR (95%CI) 
Yes No 
35,264 (87.3%) 5128 (12.7%) 
Age group 
 41–49 years 9540 (23.61%) 9113 (25.84%) 423 (8.25%) 12.84 (11.48–14.37) 
 33–40 years 9799 (24.25%) 9315 (26.42%) 478 (9.32%) 11.85 (10.64–13.19) 
 25–32 years 11,251 (27.84%) 10,331 (29.3%) 915 (17.84%) 6.65 (6.10–7.24) 
 18–24 years 9820 (24.3%) 6505 (18.45%) 3312 (64.59%) Ref. 
Educational level 
 No education 1029 (2.55%) 794 (2.25%) 233 (4.54%) 0.78 (0.65–0.93) 
 Primary 11,355 (28.1%) 10,203 (28.93%) 1150 (22.43%) 1.69 (1.54–1.86) 
 Secondary 18,722 (46.33%) 16,175 (45.87%) 2536 (49.45%) 1.03 (0.69–1.12) 
 Higher 9304 (23.02%) 8092 (22.95%) 1209 (23.58%) Ref. 
Wealth quintiles 
 Lowest 9700 (24%) 7943 (22.52%) 1751 (34.15%) 0.60 (0.52–0.69) 
 Lower 10,335 (25.58%) 9033 (25.62%) 1298 (25.31%) 0.80 (0.70–0.91) 
 Middle 8474 (20.97%) 7530 (21.35%) 937 (18.27%) 0.87 (0.77–0.99) 
 Higher 6586 (16.3%) 5929 (16.81%) 656 (12.79%) 0.94 (0.82–1.07) 
 Highest 5315 (13.15%) 4829 (13.69%) 486 (9.48%) Ref. 
Working status 
 No 4182 (10.35%) 3135 (8.89%) 1045 (20.38%) 0.38 (0.35–0.41) 
 Yes 36,228 (89.65%) 32,129 (91.11%) 4083 (79.62%) Ref. 
Type of health insurance 
 Non-affiliated 4627 (11.45%) 3653 (10.36%) 973 (18.97%) 0.30 (0.27–0.33) 
 Subsidised 20,691 (51.2%) 17,630 (49.99%) 3049 (59.46%) 0.51 (0.47–0.55) 
 Special 1112 (2.75%) 1033 (2.93) 79 (1.54%) 1.21 (0.95–1.55) 
 Contributory 13,980 (34.6%) 12,948 (36.72%) 1027 (20.03%) Ref. 
Area of residence 
 Rural 10,948 (27.09%) 9264 (26.27%) 1682 (32.8%) 0.86 (0.79–0.93) 
 Urban 29,462 (72.91%) 26,000 (73.73%) 3446 (67.2%) Ref. 
Region of residence 
 Amazon-Orinoquía 6923 (17.13%) 5697 (16.16%) 1223 (23.85%) 0.69 (0.55–0.86) 
 Pacific 5875 (14.54%) 5190 (14.72%) 683 (13.32%) 1.00 (0.82–1.23) 
 Central 9948 (24.62%) 9028 (25.6%) 914 (17.82%) 1.28 (1.07–1.55) 
 Atlantic 8399 (20.78%) 7114 (20.17%) 1281 (24.98%) 0.70 (0.58–0.84) 
 Eastern 9265 (22.93%) 8235 (23.35%) 1027 (20.03%) Ref. 
Have had children 
 Yes 33,294 (82.39%) 30,690 (87.03%) 2586 (50.43%) 10.22 (9.46–11.05) 
 No 7116 (17.61%) 4574 (12.97%) 2542 (49.57%) Ref. 
Final say on own health 
 Someone else 4914 (12.16%) 3489 (9.89%) 1423 (27.75%) 0.30 (0.28–0.33) 
 Woman and other 4612 (11.41%) 4083 (11.58%) 529 (10.32%) 0.41 (0.83–1.01) 
 Woman alone 30,884 (76.43%) 27,692 (78.53%) 3176 (61.93%) Ref. 
Note: All χ2 tests were significant (p-values < 0.0001). 
a 18 missing values in the outcome variable (excluded from analysis). 
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Fig. 3-1.  Hierarchical structure of the 2010 NDHS data. 
 
Unconditional analyses between each predictor and the outcome in the multilevel model were 
conducted and unadjusted odds ratios (UOR) were computed. Risk factors with unconditional p-
values≤ 0.2 (27) were retained for consideration in the multivariable analysis. A manual 
backward selection strategy was used to build the multivariable model, removing the predictor 
with the highest p-value, one at a time until only variables with p<0.05 remained. Categorical 
variables with more than two categories were assessed using a type-3 likelihood ratio test. The 
linearity assumption of age was tested using a quadratic term. Age was used as a four-category 
variable given that the linearity assumption was not met (p<0.001). Observations with missing 
values were removed from the analysis. Potential confounders were retained in the final model if 
including the variable changed the coefficients of other variables of interest by >10%. 
Interactions were assessed between the retained main effects in the multivariable model and 
rural/urban residence; interactions were considered significant if p<0.05. Post hoc comparisons 
were used to explore differences across multiple categories. A contextual effect measuring the 
prevalence of no education in the neighbourhoods was examined for an association with having 
had a Pap test. Finally, an interaction was examined between the prevalence of no education 
within each neighbourhood and an individual woman's educational level. 
 
Population-averaged odds ratios (OR) and their corresponding 95% confidence intervals 
(95%CI) were computed using population-averaged coefficients (𝛽PA) calculated from the final 
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multivariable model. Using subject-specific coefficients (𝛽SS) from the final multivariable 
model, the following formula was employed: 𝛽𝑃𝐴 ≈ 𝛽𝑆𝑆 √(1 + 0.346[𝜎𝜈2+𝜎𝜇2])⁄  (27), where 𝜎𝜈2 
was the municipality level variance and 𝜎𝜇2 represented the neighbourhood level variance. 
 
In the null model, the variance partition coefficient (VPC) was computed for the 
neighbourhood and municipality levels to measure clustering in the probability of having had a 
Pap test. The VPCs were computed using the latent response variables approach (29). For the 




2 + 3.29)⁄ . 
 
Akaike's Information Criterion (AIC) was used to compare the fit of competing models (27). 
The adequacy of the final model was assessed using plots of the standardised residuals for the 
neighbourhood and municipality levels, and receiver-operating characteristic (ROC) curves. 
Statistical analyses were completed in STATA 12 (StataCorp LP, College Station, TX, USA) at a 
5% level of significance. 
 
3.3. Results 
The mean age of the 40,410 women, who provided information on CC screening, was 32.4 
years (SD = 9.0); socio-demographic characteristics of the sample are presented in Table 3-1. In 
total, 87.3% of 40,392 women reported having had a Pap test. Only 18 women (<0.1%) had 
missing information about having had a Pap test. 
 
The average numbers of women per neighbourhood and municipality were 8.2 and 156, 
respectively. Clustering by individual household was not included, as the average number of 
participating women per household was less than two and 72.9% (29,469/40,410) of units were 
not replicated. In the null multilevel model (including only the random intercepts), 4.8% and 
5.6% of the total variability in the dependent variable was explained by the neighbourhood and 
municipality levels, respectively. All of the risk factors examined were unconditionally 
associated with the likelihood of having had a Pap test, p-values<0.0001 (Table 3-1). Similar 
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associations were also identified in a sub-group analysis of women aged 25–49 years (data not 
shown). 
3.3.1. Multilevel Multivariable Analysis 
Rural/urban residence was initially removed from the model during the backward selection 
process; all other variables were retained. However, rural/urban residence was identified as a 
confounder of the variable describing whether the women had the final say on their own health. 
Additionally, rural/urban residence modified the effect of education (p=0.03), type of insurance 
(p=0.01), age group (p<0.001), and region of residence (p<0.001). The model with four 
interaction terms with rural/urban residence fit substantially better (AIC=22,691) than the model 
without rural/urban residence interactions (AIC=22,729). 
The prevalence of no education within the neighbourhoods was a contextual factor also 
associated with having had a Pap test (p =0.005) (AIC=22,688). Finally, the interaction between 
the prevalence of no education within the neighbourhoods and the educational level of women 
was significant (p=0.009). Thus, the final model including the contextual effect and interactions, 
as described above, had the best fit of those examined (AIC=22,683); this model is presented in 
the Appendix C. Standardised residuals for the neighbourhoods and municipalities were within 
the acceptable range of ±3 standard deviations from zero. The ROC curve suggested the model 
had good discrimination power (area under the curve=0.87; 95%CI=0.87–0.88). 
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Table 3-2. Population-averaged odds ratios (OR), 95%CI, and p-values for risk factors for having 
had a Pap test among Colombian women from the final multivariable model. Effect estimates 
reported here were not modified by other variables but were adjusted for other factors in the final 
three-level logistic regression model (n = 40,392). 
Predictors OR 95%CI p* 
Wealth quintiles 
 Lowest 0.70 (0.58–0.84) <0.001 
 Lower 0.85 (0.72–1.00) 0.05 
 Middle 0.91 (0.79–1.06) 0.23 
 Higher 0.90 (0.78–1.04) 0.14 
 Highest Ref. 
Working status 
 No 0.63 (0.57–0.69) <0.001 
 Yes Ref. 
Have had children 
 Yes 5.52 (5.06–6.02) <0.001 
 No Ref. 
Final say on own health 
 Someone else 0.62 (0.57–0.67) <0.001 
 Woman and other 1 (0.90–1.11) 0.99 
 Woman alone Ref. 
  
* p-values for subject specific coefficients.
As summarised in Table 3-2, being in the lowest wealth quintile decreased the likelihood of 
having had a Pap test when compared to being in the highest quintile (OR=0.7, p<0.001). 
Women whose final health decisions depended on somebody else were less likely to have had a 
Pap test than those who made their own health care decisions (OR=0.62, p<0.001). Also, Pap 
testing was less likely among those who were unemployed compared to those who were 
employed (OR=0.63, p<0.001). In contrast, women with children were more likely to have had a 
Pap test compared to those who did not have children (OR=5.52, p<0.001). 
The difference in the odds of having a Pap test among age groups, type of insurance, and 
region of residence varied based on rural/urban residence. In both rural and urban areas, women 
in the youngest age group, living in the Amazon-Orinoquía and Atlantic regions, with subsidised 
insurance, and those with no insurance were less likely to have had a Pap test (Table 3-3). For 
instance, women living in rural (OR=0.63, p<0.001) and urban (OR=0.55, p<0.001) areas with 
subsidised insurance had lower odds of having Pap testing compared to women with contributory 
insurance. 
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After accounting for other risk factors, women living in rural areas were less likely to have a 
Pap test than women in urban areas (Fig. 3-2, Table 3-4). However, the difference between 
women with limited-to-no education and those with higher education was greater for those living 
in neighbourhoods with a higher prevalence of no education in both rural and urban areas (Table 
3-4). For instance, among women living in neighbourhoods with 0% prevalence of no education,
the odds of having a Pap test for women with no education living in rural areas were 0.32 
(95%CI=0.20–0.49) times that of women with higher education living in rural areas. 
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Table 3-3. Population-averaged odds ratios, 95%CI, and p-values for risk factors for having had 
a Pap test from the final three-level multivariable model. Variables reported here include 
interactions between rural/urban residence and age group, type of insurance, and region. 
Comparisons OR 95%CI p* 
Women living in rural areas 
 Age group 
  18–24 vs. 25–32 years 0.26 (0.22–0.30) <0.001 
  18–24 vs. 33–40 years 0.20 (0.16–0.23) <0.001 
  18–24 vs. 41–49 years 0.22 (0.18–0.27) <0.001 
  25–32 vs. 33–40 years 0.76 (0.63–0.92) <0.01 
 Type of health insurance 
  Subsidised vs. contributory 0.63 (0.50–0.80) <0.001 
  Subsidised vs. special 0.59 (0.44–0.78) <0.001 
  Subsidised vs. non-affiliated 1.73 (1.47–2.04) <0.001 
  Non-affiliated vs. contributory 0.37 (0.28–0.48) <0.001 
  Non-affiliated vs. special 0.35 (0.19–0.65) <0.001 
 Region of residence 
  Amazon-Orinoquía vs. Eastern 0.63 (0.47–0.85) <0.01 
  Amazon-Orinoquía vs. Central 0.38 (0.29–0.50) <0.001 
  Atlantic vs. Central 0.48 (0.37–0.63) <0.001 
  Atlantic vs. Pacific 0.60 (0.45–0.79) <0.001 
  Eastern vs. Central 0.60 (0.46–0.80) <0.001 
  Pacific vs. Central 0.47 (0.35–0.63) <0.001 
Women living in urban areas 
 Age group 
  18–24 vs. 25–32 years 0.29 (0.26–0.32) <0.001 
  18–24 vs. 33–40 years 0.17 (0.15–0.20) <0.001 
  18–24 vs. 41–49 years 0.14 (0.12–0.16) <0.001 
  25–32 vs. 33–40 years 0.60 (0.52–0.70) <0.001 
  25–32 vs. 41–49 years 0.47 (0.40–0.56) <0.001 
  33–40 vs. 41–49 years 0.79 (0.66–0.94) <0.01 
 Type of health insurance 
  Subsidised vs. contributory 0.55 (0.50–0.61) <0.001 
  Subsidised vs. special 0.59 (0.44–0.78) <0.001 
  Subsidised vs. non-affiliated 1.23 (1.09–1.38) <0.001 
  Non-affiliated vs. contributory 0.45 (0.40–0.51) <0.001 
  Non-affiliated vs. special 0.48 (0.36–0.64) <0.001 
 Region of residence 
  Amazon-Orinoquía vs. Central 0.65 (0.50–0.84) <0.001 
  Atlantic vs. Central 0.58 (0.47–0.72) <0.001 
  Atlantic vs. Pacific 0.63 (0.49–0.80) <0.001 
  Eastern vs. Central 0.61 (0.49–0.76) <0.001 
  Eastern vs. Pacific 0.66 (0.51–0.86) <0.01 
  Pacific vs. Central 0.70 (0.53–0.94) <0.01 
Note: Non-statistically significant comparisons (p ≥ 0.05) are not presented in this table. 
* p-values for subject specific coefficients.
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Fig. 3-2. Probability of having a Pap test 
among women living in rural and urban areas 
according to age group, type of health 
insurance, and region of residence. In most 
comparisons, living in rural settings decreased 
the probability of having had a Pap test, 
particularly among young women (a), those 
with no insurance or with subsidised health 
insurance (b), and women living in the 
Atlantic and the Amazon-Orinoquía regions 
(c). 
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Table 3-4. Population-averaged odds ratios, 95%CI, and p-values for risk factors for having had a Pap test from the final three-level 
multivariable model. Variables reported here include interactions between rural/urban residence and educational level, considering 
three scenarios of prevalence of no education in neighbourhoods. 
Prevalence of no education in neighbourhoods where women lived 
Comparisons 0% 20% 50% 
OR 95%CI p* OR 95%CI p* OR 95%CI p* 
Between urban and rural areas a 
No education vs. no education 2.14 (1.35–3.39) <0.001 2.14 (1.35–3.39) <0.001 2.14 (1.35–3.39) <0.001 
Primary vs. primary 1.39 (1.04–1.87) 0.03 1.39 (1.04–1.87) 0.03 1.39 (1.04–1.87) 0.03 
Secondary vs. secondary 1.76 (1.34–2.31) <0.001 1.76 (1.34–2.31) <0.001 1.76 (1.34–2.31) <0.001 
Higher vs. higher 1.63 (1.14–2.35) 0.01 1.63 (1.14–2.35) 0.01 1.63 (1.14–2.35) 0.01 
Within women living in rural areas 
No education vs. primary 0.43 (0.30–0.61) <0.001 0.43 (0.34–0.55) <0.001 0.44 (0.29–0.65) <0.001 
No education vs. secondary 0.43 (0.30–0.62) <0.001 0.31 (0.24–0.42) <0.001 0.20 (0.12–0.33) <0.001 
No education vs. higher 0.32 (0.20–0.49) <0.001 0.19 (0.11–0.32) <0.001 0.09 (0.03–0.27) <0.001 
Primary vs. secondary 0.99 (0.85–1.15) 0.88 0.73 (0.59–0.90) 0.003 0.46 (0.27–0.76) 0.003 
Primary vs. higher 0.74 (0.55–0.98) 0.04 0.44 (0.27–0.72) 0.001 0.21 (0.07–0.63) 0.005 
Secondary vs. higher 0.74 (0.57–0.97) 0.03 0.61 (0.37–0.99) 0.05 0.45 (0.14–1.41) 0.17 
Within women living in urban areas 
No education vs. primary 0.66 (0.47–0.94) 0.02 0.66 (0.48–0.92) 0.01 0.67 (0.39–1.14) 0.14 
No education vs. secondary 0.52 (0.37–0.73) <0.001 0.38 (0.27–0.54) <0.001 0.24 (0.13–0.44) <0.001 
No education vs. higher 0.42 (0.29–0.59) <0.001 0.25 (0.15–0.42) <0.001 0.12 (0.04–0.37) <0.001 
Primary vs. secondary 0.78 (0.69–0.89) <0.001 0.57 (0.46–0.72) <0.001 0.36 (0.21–0.62) <0.001 
Primary vs. higher 0.63 (0.54–0.73) <0.001 0.38 (0.24–0.60) <0.001 0.18 (0.06–0.54) 0.002 
Secondary vs. higher 0.8 (0.72–0.89) <0.001 0.66 (0.42–1.04) 0.07 0.49 (0.15–1.53) 0.22 
* p-values for subject specific coefficients.




The proportion of women who have had at least one Pap test varies across and within 
countries (14, 15, 30-33). In this 2010 study, we found that 87% of the women in Colombia have 
ever had a Pap test. Other Colombian studies have identified similar results. In 2006, in Medellín 
(Eastern region), about 85% of women reported having had a Pap test (32), and in 2005, in a 
nationwide sample, 90% of women between 25 and 69 years reported having a recent Pap test 
(15). In contrast, a 1998–1999 study found that 67% of women had a Pap test in a municipality 
located in the Eastern region (14), and another study in 2007 identified that 56% of university 
students living in a city located in the Pacific region had at least one Pap test (33). 
Notwithstanding, our results provide a recent nationwide figure of Pap testing among Colombian 
women, evaluating differences by socioeconomic and contextual factors. 
Several Colombian (15, 16, 32) and Latin American studies (34) suggest the existence of 
substantial differences in Pap test access based on the socioeconomic conditions of women. 
Moreover, living in rural areas exacerbated other challenges to Pap testing. Soneji and Fukul (34) 
found that rural residence significantly decreased the probability of having a recent Pap test in 
Nicaragua, Ecuador, and Peru. In Colombia, women living in rural regions have a lower health 
status (35) and face high poverty levels, poor possibilities for having a job and receiving a fair 
income, and limited access to housing, education and health care (36). Other problems in rural 
Colombia are the distance between one's home and a health care centre (14, 24), violence and 
war, high vulnerability of youth and women (37), and a lack of knowledge about the SGSSS and 
the health care rights that citizens have (38). 
We observed that having a rural/urban residence modified the effect of age, type of health 
insurance, region, and education on having had a Pap test. Other authors have reported that 
younger women have reduced probabilities of having Pap test (14, 16, 25, 31, 32), especially if 
residing in rural areas (14). Although better coverage of subsidised health insurance in rural 
areas has been reported in Colombia (21), people with subsidised health insurance receive 40% 
less health care compared to those with contributory health insurance (21). In this regard, our 
results also show that women in rural areas with subsidised insurance have a lower probability of 
having had a Pap test. This finding supports that having health insurance does not ensure 
67 
accessing health care services in Colombia (24). Not having health insurance is also a critical 
factor for not having a Pap test (15, 25), especially in rural areas (15). Barriers for enrolling, co-
payments established by health insurance companies, or lack of specialists are difficulties faced 
by rural people with no insurance in Colombia (39). Additionally, Pap screening in the Atlantic 
and Amazon-Orinoquía regions is particularly poor (40), especially in rural areas, as we 
identified. 
Our study demonstrates the remarkable role of education at the individual and neighbourhood 
levels. Limited access to education decreases the Pap test uptake, particularly in rural locations. 
Education is critical to access information about CC screening programmes (15, 32, 34), know 
the role of the human papillomavirus infection (41) and other risk factors (30), and decrease 
myths about the Pap test (42). Moreover, lack of awareness of Colombian citizen health care 
rights makes Colombians more vulnerable by limiting their capacity to access health services and 
perpetuating the ineffectiveness of bureaucracy (24). This highlights the importance of education 
in access to health care in Colombia, including Pap testing. Coughlin et al. (43) have suggested 
that the context has a supplementary role in the uptake of Pap tests. We found that the 
differences among women with different educational backgrounds were greater in areas that had 
a higher prevalence of no education, suggesting that the impact of education on Pap testing goes 
beyond individual educational achievement. Additionally, negative opinions of neighbours or 
peers about Pap screening influence the willingness of women to have the test (44, 45). Certain 
attitudes of partners could make participating in CC screening programmes difficult (44); 
machismo and jealously of partners are obstacles women experience when seeking a Pap test, 
especially if the health care provider is male (45, 46). In contrast, support from partners, 
children, and family members increases women's likelihood of having a Pap test (44). 
Furthermore, feeling ownership of one's body is described as a critical factor for Pap test uptake 
(45, 46), explaining why women who made their own health care decisions were more likely to 
have had a Pap test. 
Unemployment has been also associated with lack of autonomy and decreased access to 
information about the Pap test (25), explaining why not working was associated with lower 
reports of Pap test uptake. Notwithstanding, having a job in Colombia does not necessarily mean 
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having health insurance (47) despite affiliation with a health insurance provider is mandatory for 
employees and self-employed individuals (17). Another obstacle for having Pap testing is that 
women are implicitly acknowledging to family and peers that they are or have been sexually 
active (44, 48); fear of negative reactions from parents or others in authority could be a barrier 
for Pap screening by young and single women (44). On the other hand, having children has been 
associated with increased uptake of Pap tests (15, 25, 48) because women want to be healthy so 
they can look after their families (44), and also because maternity often exposes women to health 
care services. 
One of the limitations of the present study is that self-reported information might not 
represent the actual Pap test coverage in Colombia. Test uptake could be overestimated or 
underestimated because of social desirability and lead to misclassification bias (31). Using 
objective measures about CC screening has been recommended to overcome this problem (49). 
Because this was a cross-sectional study, caution is necessary in assuming cause-effect 
relationships between risk factors and Pap test uptake, particularly for factors where risk changes 
over time. 
In conclusion, 13% of the women who participated in this study and were eligible for CC 
screening in Colombia never had a Pap test. This nationwide study demonstrates the continued 
presence of inequities and a social gradient for the uptake of Pap tests which need to be 
considered when planning and evaluating CC programmes. The likelihood of having had a Pap 
test was lowest among poor, unemployed, and women whose health care decisions depended on 
others. Furthermore, having a rural residence decreased the probability of Pap testing among 
younger women, those with no health insurance, living in isolated regions, and those with 
limited-to-no education. A context of high prevalence of no education in the neighbourhood 
decreased Pap test uptake, particularly among women living in rural areas. Specific strategies 
should be developed to consider individual and contextual factors when designing new 
approaches to increase participation of women in CC screening programmes. Efforts to improve 
access to CC screening should focus on disadvantaged populations, especially among those 
living in rural/isolated areas. 
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CHAPTER 4 – SPATIAL VARIATIONS IN CERVICAL CANCER PREVENTION IN 
COLOMBIA: GEOGRAPHICAL DIFFERENCES AND ASSOCIATED SOCIO-
DEMOGRAPHIC FACTORS 
Article reproduced with minor edits and with permission. Published on-line as: “Bermedo‐
Carrasco S, Waldner C, Peña‐Sánchez JN, Szafron M. Spatial variations in cervical cancer 
prevention in Colombia: Geographical differences and associated socio-demographic factors. 
Spat Spatiotemporal Epidemiol. 2016; 19:78-90. http://dx.doi.org/10.1016/j.sste.2016.07.002.” 
My contributions to this study included the study design, data acquisition and analysis, 
interpretation of the results, and preparation of the manuscript. 
Chapter 4 builds on the individual and local factors associated with primary and secondary 
cervical cancer (CC) prevention presented in the previous chapters. Chapter 4 presents the results 
of spatial clustering analysis and risk ratio maps that identified an increased risk of a lack of 
HPV vaccination awareness and Pap testing among socially deprived departments and those 
adjacent to the Colombian border. This study provides evidence of similar spatial patterns in 
access to primary and secondary CC prevention by Colombian departments, after accounting for 
area-based socio-demographic factors, such as percentages of women with lack of education, 
subsidised insurance, and rural residence. The study further identifies departments where the low 
rates of primary and secondary CC prevention are not completely explained by the individual 
risk factors identified in previous chapters, suggesting the need for further study. The study 
results could guide decision makers and health care practitioners to target high-risk areas in 




Worldwide, 528,000 women were diagnosed with cervical cancer (CC) and 266,000 CC 
related deaths were reported in 2012 (1). Cervical cancer is a preventable disease (2) that 
inequitably impacts less developed regions of the world (1). Thousands of young women in 
developing nations continue to be diagnosed and die due to CC (3). In Latin America, nearly 
69,000 new CC cases were estimated in 2012. The 2012 age-standardised incidence rate of CC in 
Colombia was 18.7 per 100,000, which is higher than the rates for Costa Rica, Chile, and Brazil, 
but lower than those for Bolivia, Nicaragua, and Paraguay (1). Limited access by women to CC 
prevention programmes (4), socio-cultural and economic barriers, and organisational challenges 
to CC prevention programmes have been described as obstacles to decreasing the burden of CC 
in Latin America (5).   
A combination of primary and secondary strategies is recommended for preventing CC (5, 6). 
While primary prevention aims to reduce the occurrence of disease among susceptible 
individuals (e.g. through disease education, vaccination, health promotion), secondary prevention 
seeks to reduce the burden of illness and improve outcomes by case-finding early in the disease 
process (e.g. through screening) (7). Although education has been described as a key factor for 
the success of CC prevention programmes (8), Colombian studies have shown limited 
knowledge and awareness of the human papillomavirus (HPV) and its role in the development of 
CC (9), as well as the importance of HPV vaccination (10, 11). While in one study 77% of 
Colombian women reported participating in CC screening programmes (i.e., Pap testing) in the 
previous three years, there are still many women with limited access to Pap testing in Colombia 
(4).   
Among Colombian women, different factors have been associated with the lack of Pap testing 
and not having heard of HPV vaccination. Having a limited education (9), living in rural areas 
(11), and having subsidised health insurance (11) have been associated with limited access to CC 
prevention programmes. Population density might also be an indicator of whether women 
participate in CC prevention initiatives, because of the association between population density 
and access to health care (12). 
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While spatial variations in CC mortality have been described (13) across the 33 Colombian 
administrative divisions, called departments (32 departments and the Capital District, Bogotá, 
D.C.), spatial analyses of primary and secondary CC prevention have not been reported to date.
The spatial analysis of primary and secondary CC prevention data could improve our 
understanding of geographical variations in risk (14) and identify any spatial patterns and disease 
clusters (15).  
The overall goal of this study was to identify spatial variations in both the department 
frequencies of young women who have never heard of HPV vaccination and the department 
frequencies of young women in Colombia who have never had Pap testing. The first objective of 
this study was to use global and local tests for clustering to describe spatial patterns in the 
department frequencies of women aged 13-49 years who had not heard of HPV vaccination 
(NHrd-Vac) and the department frequencies of women aged 18-49 years who had not had Pap 
testing (NHd-Pap). The second objective was to examine whether the identified spatial patterns 
could be explained by department-level differences in socio-demographic attributes among 
women, including a lack of formal education, having subsidised health insurance, and living in 
rural areas, as well as differences in department population density. 
4.2. Methods 
4.2.1. Data Sources 
Data aggregated by Colombian departments (Appendix D) were used for this ecological 
study. The data were obtained from the 2010 Colombian National Demographic and Health 
Survey (NDHS) and the Colombian National Administrative Department of Statistics 
(Departamento Administrativo Nacional de Estadística–DANE). The 2010 NDHS was a 
representative nationwide survey comprising health information reported by 53,521 women aged 
13-49 years (16). The 2010 department total population estimates used in this study were made
available by DANE (17). 
Two CC prevention outcomes were summarised for each department from the 2010 NDHS: 1) 
the relative frequency of NHrd-Vac in women aged 13-49 years; and 2) the relative frequency of 
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NHd-Pap in women aged 18-49 years. To compute the relative frequency of NHrd-Vac women 
in a given department, the numerator was the department number of women aged 13-49 who 
never heard of HPV vaccination (those who had not heard of HPV and a vaccine to prevent CC), 
and the denominator was the total department number of women aged 13-49 years surveyed in 
the 2010 NDHS. To compute the relative frequency of NHd-Pap women by department, the 
numerator was the department number of women aged 18-49 years who reported never having 
had Pap testing, and the denominator was the department total number of eligible women aged 
18-49 years surveyed about CC prevention in the 2010 NDHS. According to the NDHS, women
eligible to answer CC questions were those 18 years or older, who had experienced intercourse, 
and did not have a hysterectomy (16).  
To describe socio-demographic risk factors, department percentages of women with no 
education (hereinafter called no education), having subsidised health insurance (hereinafter 
called subsidised insurance), and living in rural areas (hereinafter called rurality) were calculated 
for women aged 13-49 and 18-49 years. These percentages were used as potential risk factors for 
NHrd-Vac and NHd-Pap. Furthermore, the 2010 population density (hereinafter called density) 
was calculated per department as the total department population divided by the area of the 
department (in km2). The five geographic regions established in the 2010 NDHS were used to 
summarise results across departments (Appendix D). 
4.2.2. Spatial Clustering 
For both outcome variables (frequencies of NHrd-Vac and NHd-Pap women), global and 
local clustering tests were used to identify aggregations of cases (18). To determine if global 
clustering was present, a global Moran’s I for each study outcome was calculated using the 
empirical Bayes index proposed by Assunção and Reis (19, 20) via Monte Carlo simulation 
through the spdep package in the R software (21). This index used either the age-specific number 
of NHrd-Vac women or the number of NHd-Pap women as the numerator and the total 
department age-specific number of women as the denominator to account for the underlying 
population at risk (19). Neighbouring departments were defined using a first-order Queen 
argument, accounting for the spatial relationships of departments sharing borders and corners 
(20). 
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Kulldorff’s spatial scan statistics (SaTScan software, version 9.4.1) were used to identify the 
local clusters for each study outcome (22). The null hypothesis for the underlying test assumed 
that the risk of NHrd-Vac women and then NHd-Pap women was equally likely inside and 
outside a circular window that summarised the observed and expected outcomes for each 
department (22). This test was computed using a purely spatial Poisson probability model via 
Monte Carlo simulation (23) with the maximum spatial cluster size of the population at risk set 
to 50% of population at risk. 
4.2.3. Model Building 
4.2.3.1.Expected number of cases 
The expected numbers of NHrd-Vac and NHd-Pap women were estimated for each of the 
Colombian departments. These estimates were determined assuming a constant risk across all 
departments in the country (24) using the formula (25): 𝑒𝑖 = (Σ𝑖𝑦𝑖 Σ𝑖𝑦𝑖𝑃⁄ ) ∙ 𝑦𝑖𝑃, where, for
department i, 𝑒𝑖 was the expected number of cases for an outcome in the department, 𝑦𝑖 was the 
observed number of cases in the department, and 𝑦𝑖𝑃 was the number of women surveyed in the
NDHS in the department. To estimate the expected number of NHrd-Vac women, 𝑦𝑖 was the 
number of surveyed women aged 13-49 years in department i who never heard of HPV 
vaccination, and 𝑦𝑖𝑃 was the number of surveyed women aged 13-49 years in department i. To
estimate the expected number of NHd-Pap women, 𝑦𝑖 was the number of surveyed women aged 
18-49 years in department i who reported never having had Pap testing, and 𝑦𝑖𝑃 was the number
of at-risk women aged 18-49 years surveyed in department i. 
4.2.3.2.Modelling department risk of NHrd-Vac and NHd-Pap 
Two multilevel Poisson models were created in STATA 12 (StataCorp LP, College Station, 
TX, USA) using generalised linear mixed models (GLMM) with department number as a random 
intercept. These models were used to assess how the socio-demographic factors of interest were 
associated with the department relative frequencies of NHrd-Vac and the department relative 
frequencies of NHd-Pap women.  
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Due to unmet linearity assumptions between no education and density and the dependent 
variables, no education and density were recoded as binary variables. The resulting categories of 
no education were created based on the national prevalence of no education for women aged 13-
49 and for women aged 18-49. Departments were classified for each age group as “1=at or above 
the national prevalence of no education” or “0=below the national prevalence of no education.” 
For the NHrd-Vac model, the categories of population density were created based on the 2010 
Colombian population density. Departments were classified as “1=below the national population 
density” or “0=at or above the national population density.”  
Unconditional analyses were completed, using p<0.2 to identify variables to be considered in 
subsequent model building (26). A manual forward strategy was followed, using likelihood ratio 
tests to compare full and reduced models.  
Confounding factors were identified and retained in the model if including the factor resulted 
in a >10% change in a coefficient estimate for another study variable. Then, for each of the two 
resulting multivariable models, all possible two-way interactions were assessed between 
significant risk factors and confounders and were retained and reported if p<0.05.  
To confirm the variables included in the two STATA-built models, the models were re-
examined in WinBUGS version 1.4.3 (27). In each model, two zero mean Gaussian random 
effects were incorporated to account for the spatially structured (μ) and unstructured (v) 
heterogeneity (28). The resulting model for department i had the form: ln 𝑦𝑖 = ln 𝑒𝑖 + 𝛼 +
𝛽1𝑋1 + 𝛽2𝑋2+. . . +𝛽𝑚𝑋𝑚 + 𝜇𝑖 + 𝜐𝑖, where the expected numbers of cases (𝑒𝑖) computed for
each department were used as the offset variables (28); and α and the betas (i.e. 𝛽1, 𝛽2, …, 𝛽𝑚) 
respectively represented the intercept and the coefficients of the independent variables 
𝑋1, 𝑋2, … , 𝑋𝑚 in the fixed-effects model. Additionally, 𝜇𝑖 and 𝜐𝑖 respectively represented the 
spatially structured and unstructured heterogeneity for department i. The exponentiated value of 
(ln(𝑦𝑖) − ln(𝑒𝑖)) or (𝑦𝑖 𝑒𝑖⁄ ) represented the predicted risk of the outcome in each department
relative to the expected value based on the national average risk or the predicted risk ratio for the 
department. 
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To represent the magnitude of the spatially structured and unstructured heterogeneity on a 
scale comparable to the fixed effects in the two models, median risk ratio ratios (RRRM) were 
calculated for each random effect using an adaptation of the formula for the median incidence 
rate ratio (29): 𝑅𝑅𝑅𝑀(𝜎𝑔) = exp (0.954 ∙ 𝜎𝑔), where 𝜎𝑔 was the standard deviation of either the 
spatially structured (g=μ) or unstructured (g=v) random effects in each of the models.  
4.2.3.3.Bayesian analyses 
The WinBUGS models used Bayesian applications to estimate the parameters and random 
effects in our models. Non-informative priors (i.e. priors with a normal distribution, a mean of 0, 
and a large variance or small precision equal to 0.00005) were used for all regression coefficients 
in both models (30).  
The structured spatial heterogeneity (𝜇𝑖) incorporated a Gaussian conditional autoregressive 
(CAR) prior distribution as the spatial correlation structure (28, 31). The unstructured 
heterogeneity (𝜐𝑖) was assigned a gamma distribution for the precision (or inverse variance) with 
a mean of 0.5 and a variance of 0.0005 (28). 
Estimates of differences among predicted values associated with fixed effects of the socio-
demographic factors were reported from the Bayesian analyses as risk ratio ratios (RRR) along 
with 95% credible intervals (Cr. I) (32). Risk ratio (RR) maps (28) were created in ArcGIS 
version 10.1 (ESRI, Redlands, California, USA) to visually depict quartiles of the differences 
observed among departments. 
The burn-in period (T=100,000 time steps) was selected for the two models based on 
characteristics of the Brook-Gelman-Rubin diagnostic plots (33). The time between independent 
samples was estimated to be 10,000 (burn-in period/10) (34). In order to have sufficient power 
for the analysis, based on the number of variables in the analysis, the number of independent data 
points required for the analysis was estimated to be 100 (35). Combining these two estimates, the 
simulation for each Markov chain needed to be run for a minimum of 1,000,000 time steps after 
80 
the burn-in period. To ensure that any data generated from the non-stationary distribution of the 
Markov chain minimally biases the parameter estimates, the burn-in period should be less than 
5% of the length of the simulation (34); following this, each Markov chain was simulated for 
T=2,100,000 time steps. We sampled every 100th observation after the burn-in period to 
decrease the correlation between successive sample points (36). To decrease the errors associated 
with the estimates for the models, four Markov chains were employed for each model (36). 
To confirm the Markov chains were sampling from their stationary distributions, we used the 
convergence diagnosis and output analysis (CODA) for Markov chain Monte Carlo (37) 
calculated using the R software package (21). Specifically, the Gelman and Rubin (33), Geweke 
(38), Raftery-Lewis (39), and Heidelberger-Welch (40) diagnostic tests were computed on data 
sampled at every time step (32). The Raftery-Lewis diagnostic was calculated on the data 
generated via sampling every 100 time-steps (41).  
4.3. Results 
Of the 53,521 women aged 13-49 years who participated in the 2010 NDHS, 39,158 (73.2%) 
reported NHrd-Vac. Of the 40,392 women aged 18-49 years who answered CC prevention 
questions, 5128 (12.7%) reported NHd-Pap. The percentage of NHrd-Vac women ranged from 
52.2% in Bogotá, D.C to 90.6% in Vaupés and the percentage of NHd-Pap women ranged from 
7.6% in Antioquia to 34.4% in Guaviare (Table 4-1). By region, Amazon-Orinoquía had the 
highest percentage (85.5%) of women NHrd-Vac, while for NHd-Pap, the Atlantic and Amazon-
Orinoquía regions had the highest percentages (16.4% and 16.3%, respectively) compared to the 
other regions.  
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Table 4-1.  Frequency distributions of women aged 13-49 years who never heard of HPV 
vaccination (N=53,521) and women aged 18-49 years who reported ever having had Pap testing 
(N=40,392) by Colombian departments, 2010. 
Region Department 
Women aged 13-49 years 
who had not heard of HPV 
vaccination (%) 
Women aged 18-49 years 
who had not had 
Pap testing (%) 
National 39,158 (73.2) 5128 (12.7) 
Eastern 
Bogotá D.C 1926 (52.2) 269 (9.2) 
Boyacá 1142 (74.7) 112 (9.9) 
Cundinamarca 1103 (69.2) 143 (11.8) 
Meta 1054 (77.4) 96 (9.1) 
Norte de Santander 1458 (75.4) 215 (14.7) 
Santander 1479 (74.4) 192 (13.0) 
Atlantic 
Atlántico 1360 (72.8) 216 (16.0) 
Bolívar 1106 (74.9) 188 (17.4) 
Cesar 935 (74.9) 138 (14.8) 
Córdoba 1119 (70.8) 144 (12.8) 
La Guajira 926 (78.7) 166 (19.6) 
Magdalena 965 (73.2) 139 (14.3) 
San Andrés y Providencia 716 (57.0) 208 (19.4) 
Sucre 1195 (77.2) 194 (17.2) 
Central 
Antioquia 2370 (68.5) 201 (7.6) 
Caldas 1207 (65.2) 118 (8.3) 
Caquetá 951 (81.1) 126 (14.4) 
Huila 938 (74.3) 103 (10.8) 
Quindío 1342 (68.8) 118 (8.0) 
Risaralda 1341 (68.3) 131 (8.7) 
Tolima 1048 (72.9) 117 (10.8) 
Pacific 
Cauca 1020 (77.3) 113 (11.4) 
Chocó 1047 (85.5) 175 (18.7) 
Nariño 1245 (83.8) 116 (10.4) 
Valle del Cauca 2339 (63.1) 279 (9.8) 
Amazon-Orinoquía 
Amazonas 1239 (86.8) 194 (25.7) 
Arauca 912 (84.4) 99 (12.2) 
Casanare 978 (83.5) 86 (9.6) 
Guainía 870 (85.5) 85 (10.0) 
Guaviare 916 (82.7) 296 (34.4) 
Putumayo 994 (84.2) 88 (9.5) 
Vaupés 1055 (90.6) 167 (22.3) 
Vichada 862 (89.0) 96 (10.1) 
The national prevalence of no education was 2.1% and 2.5%, respectively, for women aged 
13-49 and 18-49 years. The percentage of women aged 13-49 years with subsidised insurance
varied from 22.6% in Bogotá, D.C to 73.4% in Vaupés. For women aged 18-49, the percentage 
with subsidised insurance ranged from 21.9% in Bogotá, D.C to 73.8% in Chocó. The 
percentages of Colombian women aged 13-49 and 18-49 years living in rural areas were 27.3% 
and 26.6%, respectively. Women aged 13-49 and 18-49 years in the Amazonas department were 
most likely to live in rural areas (60.1% and 57.8%, respectively). The national population 
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density was 40.4 per km2 and ranged from 0.64 per km2 in Vichada to 4588 per km2 in Bogotá, 
D.C.
4.3.1. Spatial Clustering 
There were significant global spatial autocorrelations among the relative department 
frequencies of NHrd-Vac (Moran’s I=0.49, p=0.0003) and NHd-Pap (Moran’s I=0.34, p=0.004) 
women. Via Kulldorff’s spatial scan statistic, three significant clusters for both outcome 
variables were identified (Fig. 4-1). Fig. 4-1(A) illustrates the clusters for NHrd-Vac women. 
The first cluster (RR=1.18, p<0.0001) in dark grey includes ten departments. The second cluster 
(RR=1.13, p<0.0001) in medium grey includes three departments. The third cluster (RR=1.17, 
p<0.0001) in light grey consists only of the department of Chocó. Fig. 4-1(B) illustrates the 
clusters for NHd-Pap women. The first cluster (RR=2.36, p<0.001) in dark grey encompasses 
three departments. The second cluster (RR=1.36, p<0.001) depicted in medium grey includes six 
departments. Finally, the third cluster (RR=1.49, p<0.001) in light grey consists solely of the 
department of Chocó. 
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Fig. 4-1. Kulldorff’s spatial scan statistic identified three clusters with their respective risk ratios 
for each CC prevention outcome. (A) Department clusters based on the relative frequency of 
women who had not heard of HPV vaccination. (B) Department clusters based on the relative 
frequency of women who had not had Pap testing. 
4.3.2. Model Building and Results of Bayesian Analyses 
For the models of NHrd-Vac and NHd-Pap, the informal and formal diagnostic assessments 
for the Bayesian models suggested that the Markov chains reached their stationary distributions 
and that sufficient samples were collected from these distributions. For example, the results of 
the Gelman and Rubin diagnostic illustrated that the potential scale reductions estimated for the 
models were approaching 1, suggesting that the simulated values were drawn from the stationary 
distribution. For our choice of burn-in period and simulation run length for both the NHrd-Vac 
and NHd-Pap models, the Raftery-Lewis diagnostic computed dependence factor values that 
were lower than 5. The p-values in the Geweke and the Heidelberger-Welch diagnostics were 
greater than 0.05 for both models.  
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4.3.2.1.Department risk of women not having heard of HPV vaccination 
The unconditional analysis of potential predictors for the department risk of NHrd-Vac 
relative to the national average, identified no education (p=0.002), subsidised insurance 
(p<0.0001), rurality (p<0.0001), and density (p<0.0001) as possible predictors for the risk of 
NHrd-Vac. In the final Bayesian model accounting for spatially structured and unstructured 
heterogeneity by department, only subsidised insurance and density were retained. No 
confounders or significant interactions were identified. The Bayesian spatial analysis identified 
the same fixed effects structure as the frequentist GLMM model including a random intercept for 
department.   
In a given department, for every 10% increase in the percentage of women with subsidised 
insurance, the RR of NHrd-Vac increased by 1.08 times (95%Cr. I=1.06-1.09) (Table 4-2). 
Additionally, the department RR of NHrd-Vac increased by 1.07 (95%Cr. I=1.02-1.12) times if 
the population density was below the national average population density. Furthermore, the 
RRRM was 1.02 (95%Cr. I=1.01-1.04) for the spatially structured heterogeneity (μ) and 1.03 
(95%Cr. I=1.02-1.05) for the unstructured heterogeneity (v). These results suggest that the 
relative difference in the risk of NHrd-Vac between two randomly selected departments with the 
same covariate pattern relative to the national average was 1.02 times higher for departments that 
were neighbours (μ) than for departments that were not, and differed by 1.03 times due to 
heterogeneity associated with other unmeasured department factors not explained by 
neighbourhood relationships (v). 
Table 4-2.  The final multivariable model showing the association between socio-demographic 
factors and the department risk of having not heard of HPV vaccination among women aged 13-
49 years relative to the national average for Colombia, 2010. 
Variables RRR 95%Cr.I 
Subsidised insurancea 1.08b (1.06-1.09) 
Population density 
   Below the national average population density 1.07 (1.02-1.12) 
   At or above the national average population density Ref. 
a Department percentage of women with subsidised insurance 
b Relative change associated with a 10% increase in subsidised insurance 
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4.3.2.2.Department risk of women not having had Pap testing 
The unconditional analysis for the department risk of NHd-Pap relative to the national 
average, identified no education (p<0.0001), subsidised insurance (p=0.001), and rurality 
(p=0.006) as significant risk factors. Density was not a significant predictor (p=0.2) and was 
excluded from the model. In the final multivariable model, no education, rurality, and subsidised 
insurance were retained. Subsidised insurance was identified as a confounder for the association 
between no education and the department risk for NHd-Pap. The relative effect of the percentage 
of women living in rural areas varied depending on whether the percentage of women with no 
education was above or below the national average (p=0.009). The final fixed effects included in 
the NHd-Pap model formed using Bayesian spatial analysis were the same the frequentist 
random intercept GLMM. 
For each 10% increase in the percentage of women living in rural areas in departments at or 
above the national prevalence of no education, the RR of having more observed than expected 
cases of NHd-Pap women increased by 15% (RRR=1.15; 95%Cr. I=1.02-1.30) (Table 4-3). 
However, no significant differences in the RR of NHd-Pap were observed with an increasing 
percentage of women living in rural areas in departments below the national prevalence of no 
education (RRR=0.97; 95%Cr. I=0.86-1.10).  
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Table 4-3.  The final multivariable model showing the association between socio-demographic 
factors and the department risk of having not had Pap testing among women aged 18-49 years 
relative to the national average for Colombia, 2010. 
Variables RRR 95%Cr.I 
Subsidised insurancea 1.06f (0.94-1.19) 
Ruralityb in departments at or above the national prevalence of no educationc,d 1.15f (1.02-1.30) 
Ruralityb in departments below the national prevalence of no educationc,d 0.97f (0.86-1.10) 
Prevalence of no education (in an area with 26.6%e of rurality) 
   At or above the national average  1.32 (1.03-1.66) 
   Below the national average Ref. 
a Department percentage of women with subsidised insurance 
b Department percentage of women living in rural areas 
c National prevalence of no education among women 18-49 years= 2.54% 
d Interaction between percentage of women living in rural areas and whether the department was below the national 
prevalence of no education (p=0.009) 
e National percentage of women aged 18-49 years living in rural areas= 26.6% 
f Relative change associated with a 10% increase 
In a model centred at the national percentage of women living in rural areas (26.6%), 
departments where the percentage of women with no education was at or above the national 
prevalence of 2.54% were at 1.32 (95%Cr. I=1.03-1.66) times higher risk of NHd-Pap than those 
departments below the national prevalence. Similarly, in a model centred at the 75th percentile of 
women living in rural areas (39.3%), departments with a percentage of women with no education 
at or above the national prevalence of no education were at greater risk (RRR=1.63; 95%Cr. 
I=1.27-2.07) of NHd-Pap than departments below the national prevalence of no education. In 
contrast, in a model centred at the 25th percentile of women living in rural areas (21.4%), this 
difference was smaller and not significant (RRR=1.21; 95%Cr. I=0.92-1.58). 
Additionally, the median RRR of NHd-Pap comparing two randomly selected departments 
with the same covariate patterns was 1.09 (95%Cr. I=1.01-1.28) for departments that were 
neighbours (μ), and 1.19 (95%Cr. I=1.02-1.29) associated with heterogeneity due to unmeasured 
department factors not explained by location (v). 
4.3.2.3.Risk ratio maps of NHrd-Vac and NHd-Pap 
The predicted department RRs for NHrd-Vac and NHd-Pap including covariates and the 
spatially structured (μ) and unstructured heterogeneity (ν) were summarised in Fig. 4-2.  
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Chocó, in the Pacific region, and the departments located in the Amazon-Orinoquía region, 
with the exception of Casanare, were in the highest risk range of NHrd-Vac relative to the 
national average, Fig. 4-2(A). The highest risk range of NHd-Pap, Fig. 4-2(B), was identified in 
three departments in the Atlantic region (La Guajira, Sucre, and Bolívar), the department of 
Chocó (Pacific region), and four departments of the Amazon-Orinoquía region (Vichada, 
Guainía, Vaupés, and Amazonas). 
Fig. 4-2. Risk of not having heard of HPV vaccination (A) and not having had Pap testing (B) 
relative to the national average after accounting for the fixed effects, as well as the spatially 
structured and unstructured heterogeneity included in the final multivariable models for 
Colombia, 2010. The darker the shade of grey the higher the risk ratio in the department. 
Fig. 4-3(A) depicts the differences in the department RR for NHrd-Vac relative to the national 
average associated with measured risk factors included as fixed effects in the final model. The 
departments coloured in dark grey (i.e. Chocó, Arauca, Vichada, Guainía, Guaviare, Vaupés, 
Amazonas, and Putumayo; which are located in the Pacific and Amazon-Orinoquía regions) had 
the greatest component of their RR of NHrd-Vac explained by department differences in 
subsidised insurance and population density.  
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Fig. 4-3(B) shows the component of the RR explained by the location of each department and 
the relationship among neighbours (μ). The departments of Cesar, Magdalena, Atlántico, and 
Bolívar (Atlantic region), as well as departments located in the Eastern (i.e. Norte de Santander, 
Santander, and Boyacá) and Central regions (Antioquia) were in the highest RR range associated 
with spatial clustering of NHrd-Vac in women not explained by the fixed effects in the model.  
Fig. 4-3(C) depicts the differences in RR associated with the residual unstructured 
heterogeneity among departments (ν). The departments of Atlántico (Atlantic region), Antioquia 
and Tolima (Central region), Santander and Norte de Santander (Eastern region), Nariño (Pacific 
region), Meta (Eastern region), and Vichada (Amazon-Orinoquía region) were in the highest RR 
range not explained by either the fixed effects in the final model or the heterogeneity associated 
with the spatial location.  
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Fig. 4-3. Maps of the department risk ratios (RR) for not having heard of HPV vaccination in 
Colombia, 2010. (A) RR explained by fixed effects in the final multivariable model. (B) RR 
explained by the spatial structured heterogeneity (μ) or clustering. (C) RR explained by the 
unstructured heterogeneity (ν) in the model. The darker the shade of grey the higher the risk ratio 
in the department attributed to the model component. 
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Fig. 4-4(A) represents the department variation in the RR for NHd-Pap explained by the fixed 
effects in the final multivariable model. Departments located in the Amazon-Orinoquía (i.e. 
Vichada, Guainía, Guaviare, Vaupés, and Amazonas), Pacific (i.e. Chocó), and Atlantic (i.e. La 
Guajira and Córdoba) regions had the greatest component of their RR of NHd-Pap attributed to 
department differences in no education and women living in rural areas, adjusted for the 
percentage with subsidised insurance.  
Differences in the RR associated with spatial clustering (μ) are shown in Fig. 4-4(B). 
Departments located in the Atlantic (i.e. La Guajira, Atlántico, Cesar, and Bolívar), Eastern (i.e. 
Santander and Norte de Santander), and Amazon-Orinoquía (i.e. Guainía and Vaupés) regions 
had the highest RR range associated with their location.  
Fig. 4-4(C) shows the component of the RR explained by the residual unstructured 
heterogeneity (ν). Departments located in the Atlantic (i.e. Atlántico and Bolívar), Eastern (i.e. 
Norte de Santander and Santander), and Amazon-Orinoquía (i.e. Vichada, Guainía, and Vaupés) 
regions were in the highest RR range attributed to unmeasured risk factors that were not spatially 
correlated.  
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Fig. 4-4. Maps of the department risk ratios (RR) for having not had Pap testing in Colombia, 
2010. (A) RR explained by fixed effects in the final multivariable model. (B) RR explained by 
the spatial structured heterogeneity (μ) or clustering. (C) RR explained by the unstructured 
heterogeneity (ν) in the model. The darker the shade of grey the higher the risk ratio in the 
department attributed to the model component. 
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4.4. Discussion 
The methodological approach used in this study provides valuable information about the 
spatial distribution of Colombian women having limited awareness of, or access to, primary and 
secondary strategies for CC prevention. Although other local and nationwide studies in 
Colombia have measured individual factors affecting knowledge or awareness of the HPV 
vaccination and access to Pap testing (4, 10, 11, 42), we are unaware of studies assessing the 
spatial variations in CC prevention in the country. Our results identified spatial patterns of NHrd-
Vac and NHd-Pap in departments adjacent to the Colombian border. These results could be used 
to target interventions in high-risk departments and improve the awareness or participation of 
Colombian women in primary and secondary CC prevention programmes. 
The specific spatial patterns of NHrd-Vac and NHd-Pap cases identified via tests for local 
clustering are critical findings because they reveal departments in which the current CC 
prevention programmes are resulting in a lower than average awareness and uptake by local 
women. By using Bayesian spatial analysis, we also recognised and controlled for area-based 
socio-demographic factors associated with increased risk of women reporting NHrd-Vac or 
NHd-Pap. Finally, the use of spatial modelling identified residual variation due to unmeasured 
factors, suggesting that additional factors could be influencing CC prevention programmes in 
Colombia and providing a focal point for further studies. 
Women living in departments with a high prevalence of no education, subsidised health 
insurance, rurality, and low population density were more likely to report NHrd-Vac or NHd-
Pap. For example, each 10% increase in the department percentage of women with subsidised 
insurance had an 8% increase in the risk of NHrd-Vac. This finding is particularly important 
given that about 50% of Colombians are affiliated with subsidised health insurance (43), 
especially those with a low socioeconomic status and living in rural areas (44). Subsidised 
insurance has been previously associated with subscribers having limited information on HPV 
vaccination in Colombia (9-11).  
The results of our analysis demonstrated that population density was associated with NHrd-
Vac, with an increased risk when the department population density was below the national 
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average. Although previous reports have recognised that people living in departments with 
accessibility issues due to geographic location experience challenges to obtain health care 
services (e.g. Chocó, Vaupés, Vichada, Guainía, and Amazonas) (45, 46), population density has 
not previously been reported as a factor affecting the awareness of a preventive health service in 
Colombia, such as having heard of HPV vaccination. This finding might be linked to the 
shortage of health care providers described in departments located in the Pacific and Amazon-
Orinoquía regions (47), limited health care services being offered in low-populated regions, or an 
increased reticence in these areas to discuss issues related to sexuality. 
After considering the importance of department subsidised insurance, rurality, and no 
education among women, we found that the NHd-Pap risk was higher for women in the 
departments of La Guajira, Sucre, Bolívar, Chocó, Vichada, Guainía, Guaviare, Vaupés, and 
Amazonas. For departments with high rurality (e.g. above 26.6% of women living in rural areas), 
the NHd-Pap risk was higher in departments with a high percentage of non-educated women 
compared to those with a lower prevalence of no education. Also, the risk of NHd-Pap increased 
with the percentage of women living in rural areas, but only for departments with high levels of 
women with no formal education. While the interaction between education and rurality has 
previously been described at the individual level (48), the interaction between rurality and low 
education in their respective effects on the risk of NHd-Pap at the department level had not 
previously been identified in Colombia. Having a high department prevalence of no education 
and rurality would suggest a high risk of lack of Pap testing and an apparent target for 
intervention. The development of CC screening programmes must consider the differing impacts 
of rurality between departments with high and low levels of no-formally-educated women, and 
the role of high levels of no education in departments with high percentages of women living in 
rural areas. 
The results of the present study illustrate the role that department socio-demographic factors 
have in determining the risks of NHrd-Vac and NHd-Pap. Our findings support the hypothesised 
social differences between departments located in the central and peripheral areas of Colombia 
(49). Several departments in these areas of the country have poor educational, social, and health 
indicators. For example, Guainía has the lowest schooling rates, while Chocó has the highest 
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infant mortality and the lowest life expectancy in Colombia (49). Poverty and other 
socioeconomic conditions associated with ethnic diversity could account for some of the spatial 
or unstructured heterogeneity associated with the risk of NHrd-Vac or NHd-Pap observed in our 
results. Statistics from Colombia have identified the distribution of poverty by departments, 
excluding those located in the Amazon-Orinoquía region (50). The departments with a high 
percentage of population living in poverty are Cauca, La Guajira, Chocó, Sucre, and Córdoba. 
From these departments, La Guajira, Cauca, and Chocó have the highest levels of extreme 
poverty (50). Furthermore, people living in several departments of the Amazon-Orinoquía, 
Atlantic, and Pacific regions struggle to face difficulties related to inappropriate dwellings (43), a 
lack of access to basic services (43), inadequate road conditions or absence of roads (51), and 
internally displaced people (49, 52).  
To our knowledge, this is the first study conducted in Colombia that identifies spatial 
variations in accessing primary and secondary CC preventing strategies among young women. 
We described clusters where departments show a higher risk of having more cases of NHrd-Vac 
and NHd-Pap than expected and used Bayesian modelling to examine different department 
socio-demographic factors associated with these risks. Most of the socio-demographic variables 
identified by our spatial analysis have been previously recognised in Colombia as factors 
associated with individuals having not heard of HPV vaccination or having not had Pap testing 
(4, 9-11, 42, 48, 53). However, these studies did not explore department socio-demographic 
factors to explain spatial differences in CC prevention in Colombia. 
In addition to providing evidence of spatial variations in CC prevention in Colombia, the 
methods used in our study could guide the evaluation of geographical variations in cancer 
prevention programmes in different settings. Studies in other countries have explored 
geographical variations in primary and secondary CC prevention; although, these studies have 
not incorporated Bayesian analysis to estimate the importance of spatial and unstructured 
correlation among geographic regions. For example, a Canadian study identified the 
appropriateness of breast, colorectal, and CC screening in Ontario using the Local Indicator of 
Spatial Association (54). The results of this study showed low levels of screening and areas with 
low screening despite the presence of community centres or physicians’ offices nearby. A 
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German study, that used least square regressions and spatial lag models, found that cancer 
screening was better in areas with more access to health care (55). This study also identified that 
higher voter turnout was related to higher CC screening and that a longer travel time to a 
specialist’s office was negatively associated with CC screening. However, this approach 
modelled the screening rate data as a normally distributed continuous outcome and did not result 
in estimates of spatially correlated and uncorrelated errors. Our study focused on CC prevention 
awareness and access in Colombia, considering the underlying population at risk, associated 
socio-demographic factors, and the structured spatial and unstructured variations. 
While previous studies examining variations in CC incidence have incorporated a Bayesian 
spatial approach, the studies report limited diagnostics validating the simulated data used in their 
analysis. The study of Vicens et al (56) found variations in cervical and prostate cancer incidence 
in the Girona Health Region not associated with deprivation index. The authors reported the use 
of the deviance information criterion and conditional predictive ordinate to assess model fit in 
this analysis. Another study evaluated the geographic incidence of breast and cervical cancer in 
Cuba (57). The results of this study showed differences in the risk of CC in some municipalities 
and the presence of CC clusters in the municipalities located in the eastern area of Cuba. The 
authors used the deviance information criterion to assess model fit and trace and autocorrelation 
plots to check convergence of the models. The approach used in our study not only examined the 
spatial variations in NHrd-Vac and NHd-Pap by Colombian departments using Bayesian spatial 
analysis, but also included a thorough validation of the simulated data used in the analysis using 
informal and formal diagnostics.  
The results of our formal diagnostics of the simulated data used to study the Bayesian models 
support the data were sampled from a stationary distribution. Sampling from a stationary 
distribution is essential for accurately estimating parameters and random effects in a model. 
Previous studies of other health conditions, different than CC, have reported the use of some of 
the formal diagnostics included in our study. For example, a study about disparities in mortality 
due to heart attack and stroke in Tennessee (58) identified convergence based on the Brooks-
Gelman-Rubin, Geweke, and Heidelberger-Welch diagnostics. The study about the incidence of 
suicide in England and Wales used the Gelman and Rubin statistic to assess convergence of 
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chains (59). The model diagnostics that we completed included visual diagnostics, as well as the 
Gelman and Rubin, Geweke, Raftery-Lewis, and Heidelberger-Welch diagnostic tests.  
Limitations to this study include the source of the primary data. The dependent and 
independent variables extracted from the 2010 NDHS were based on self-reported information. 
These data might not be representative of the actual department prevalence of lack of HPV 
vaccination awareness (in which having not heard of HPV vaccination was used as a proxy for 
the lack of knowledge of primary prevention options for HPV), lack of Pap testing, no education, 
rurality, and affiliation to subsidised health insurance. Additionally, social desirability could be a 
factor leading to misclassification bias (60). Ecological fallacy must also be considered, although 
we did see consistency between our fixed effects results and results from previous individual-
level and multi-level studies (4, 9-11, 42, 48, 53). We also expect higher levels of collinearity 
among risk factors measured at the group level rather than at the individual level, particularly for 
socio-demographic measures (61).  
Given that CAR models could be a source of spatial confounding (62), we corroborated the 
results of the NHrd-Vac and NHd-Pap models using restricted spatial regressions (RSR) in the R 
software (63). The largest relative difference between the fixed effect estimates from RSR 
approach and the Bayesian CAR model among all of the factors contained in the final models 
was less than 5%. These results show that the use of CAR models for the analyses did not show 
substantial evidence of confounding in our results. Additionally, we confirmed the results of our 
estimates using one chain, no burn-in period, and no thinning, taking into account the 
controversial practice of burn-in, multiple chain use, and thinning (64). The relative estimates 
obtained using this approach were identical to those presented in our results.  
In conclusion, our study proposes a structured methodology to analyse spatial variations in the 
access of primary and secondary CC prevention programmes available to women in Colombia. 
Our results are relevant given the scarcity of Bayesian spatial studies about CC prevention and 
could be used to shape policies and focus resources at the department level in Colombia. We 
identified that departments adjacent to the Colombian border had a higher risk of NHrd-Vac and 
NHd-Pap. We observed that the department prevalence of subsidised insurance and population 
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density were factors related to the risk of NHrd-Vac. The risk of NHd-Pap was associated with 
the department prevalence of women with no education and rurality, accounting for the 
prevalence of subsidised insurance. Our results could be used to focus available resources in 
areas in greater need of CC prevention programmes in the country. Finally, the methodological 
approach used in this study could be successfully replicated in other settings. 
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CHAPTER 5 – THE ROLE OF SOCIO-DEMOGRAPHIC FACTORS IN PREMATURE 
CERVICAL CANCER MORTALITY IN COLOMBIA 
Article reproduced with minor edits and with permission. Originally published as: “Bermedo‐
Carrasco S, Waldner CL. The role of socio-demographic factors in premature cervical cancer 
mortality in Colombia. BMC Public Health. 2016; 16:981. http://dx.doi.org/10.1186/s12889-016-
3645-1.” My contributions to this study included the study design, data acquisition and analysis, 
interpretation of the results, and preparation of the manuscript. 
After identifying inequities in primary and secondary cervical cancer (CC) prevention in the 
previous studies, this chapter contributes with evidence on inequities in CC mortality among 
women aged 20-49 years in Colombia. This is the first study in Colombia specifically focused on 
socio-demographic factors associated with CC among young women. Differences in CC 
mortality were identified by educational level, type of health insurance, region of residence, and 
by whether women lived in urban or rural areas. Also, this is the first study in Colombia 
reporting that the inequities in CC mortality between women who were highly educated 
compared to those with no-to-limited education were relatively larger among the youngest 
compared to the oldest group. The findings of this work underline the need to plan, implement, 
and evaluate access of Colombian women to CC prevention strategies, timely diagnosis, and 




Cervical cancer (CC) imposes a high burden of disease worldwide, being the third most 
important cause of cancer-related deaths among women in 2012 (1). Developing countries 
account for almost 90% of total CC deaths (1). Developing countries are further inequitably 
impacted by premature CC deaths in young women (2), including mothers and caregivers (3) 
and, in many cases, important contributors to family income (4). In Latin American countries, 
CC caused more than 28,000 female deaths in 2012 (1). Compared to Canada and the United 
States, Latin American countries have greater age-standardised mortality rates due to CC, 
especially in Central America and countries located in the Andean region (5). In Colombia, a 
country part of the Andean region, CC has been ranked as the second most common cause of 
cancer deaths in women after breast cancer (6). 
 
While mortality rates from CC in Colombia have been decreasing in recent years (7), the 
burden of this disease continues to be an important concern (6), in spite of having effective tools 
for prevention (2). Measured as total avoidable years of life lost in Colombia, CC ranks above 
other causes of mortality, such as hypertensive heart disease or liver cancer (8). Because cancer 
in Colombia is often diagnosed in late stages, the effectiveness of potential treatment options can 
be limited (9). Additionally, many people in Colombia do not have health insurance, even though 
they can be affiliated with the contributory or subsidised system depending on their capacity to 
pay (10). Public teachers, university workers, police or military forces, and employees of the 
Colombian Oil Company have special health insurance plans (10).  
 
Previous studies in Colombia have described associations between one or two socio-
demographic factors and CC mortality focused on wider age ranges, including all women more 
than 15 years of age (11, 12) and women aged 25 to 64 years (13). Differences in CC mortality 
have been explored among departments, or Colombian administrative divisions (11, 14), rural or 
urban residence (11), educational level (12, 13), and lack of health insurance (14). However, 
there is no evidence regarding how these socio-demographic variables impact premature 
mortality associated with CC in young women (i.e. women aged 20-49 years) in Colombia, or 
how these risk factors might differentially impact younger as compared to older women under 50 
105 
years of age. The need for studies centred on young women to better understand specific risk 
factors for premature deaths from CC has previously been identified (2). 
Nationwide studies are needed to understand the specific roles of education and type of health 
insurance in CC mortality among young women in Colombia, while accounting for differences 
between urban and rural residences and variation across geographic regions. Moreover, 
variations in CC mortality between limited-to-no-educated and highly educated women by age 
group need to be explored, given that Colombian women 25 years or more tend to make more 
use of their rights to access health care (15) and that young women have low quality of 
reproductive and sexual health (16). The ability of women to act on the information they gain 
from their education might vary based on age.  
Similarly, age-specific differences in the effect of type of health insurance as a risk factor for 
CC mortality should be considered because most Colombians who use the tutela action (i.e. a 
legal constitutional mechanism to protect fundamental human rights (17)) to access health 
services had contributory health insurance (15) and older age is related to an increased utilisation 
of health care (18). As for education, the capacity of women to access the services available 
under their health insurance might vary based on their age.   
The resulting information from nationwide studies considering these variations could be used 
to identify targets for intervention in the diagnosis and treatment of young women with CC, 
taking into consideration the effect of CC on young women (2), as well as the existence of 
marked regional (19), health care system-related (20), and educational disparities in the 
Colombian population (19).  
The study described here examined differences associated with socio-demographic factors in 
CC mortality among young women in Colombia between 2005 and 2013. The objectives of this 
study were to: 1) describe socio-demographic characteristics of women aged 20-49 years who 
died from CC, 2) identify differences in CC mortality rates by educational level, type of health 
insurance, urban or rural residence, and geographic region of residence among women aged 20-
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49 years, and 3) evaluate if there were age-specific differences in the importance of education or 
type of insurance as risk factors for CC mortality. 
5.2. Methods 
5.2.1. Source of Cervical Cancer Mortality Data Stratified by Potential Risk Factors 
Official mortality records of all individuals who died in Colombia between January 2005 and 
December 2013 were obtained from the National Administrative Department of Statistics 
(Departamento Administrativo Nacional de Estadística—DANE). The causes of death in these 
records were coded according to the International Classification of Diseases—10th revision. The 
code C53 (malignant neoplasm of cervix uteri), along with applicable sub-codes (C530, 
malignant neoplasm of the endocervix; C531, malignant neoplasm of the exocervix; C538, 
overlapping lesion of cervix uteri; C539, cervix uteri, unspecified) were used to extract all 
female deaths attributed to CC by year of death. Additionally, unspecified malignant neoplasms 
of the uterus (code C55) were reallocated according to the proportion of deaths due to cervical 
(code C53) and corpus uterine cancer (code C54) by age group and year of death, as 
recommended by Loos et al (21).  
All female deaths from CC were consolidated in one data set. The socio-demographic 
characteristics of each woman, including age, educational level, type of health insurance, rural or 
urban residence, and geographic region of residence, were then extracted from the mortality 
records to be considered as potential risk factors in the analysis. From this data set, the subset of 
women aged 20-49 years was selected for analysis. The total numbers of observed CC deaths 
were stratified by age: 20-24 years, 25-29 years, 30-34 years, 35-39 years, 40-44 years, and 45-
49 years. The resulting outcome for the analysis was the age-group specific count of deaths due 
to CC further stratified by one or more of the following variables: educational level, type of 
health insurance, urban or rural residence, and department of residence. Department CC counts 
per age group were summarised for each of the five geographic regions described in the 2010 
National Demographic and Health Survey (NDHS) (22). The NDHS evaluated different factors 
associated with reproductive and sexual health in a sample of more than 53,000 women between 
13 and 49 years.  
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Mortality data used for this analysis were publicly available upon request to DANE and, 
therefore, this study was exempted from ethics review by the University of Saskatchewan Ethics 
Board. 
5.2.2. Source of Population at Risk Data Stratified by Potential Risk Factors 
The numbers of women at risk of dying due to CC for the risk factor-specific strata were 
extracted from population projections by DANE (23) and the NDHS data sets.   
In the first step, 2009 national population projections based on the 2005 census (23) were used 
to determine the population at risk categorised by the same five-year age groups used for CC 
cases. The population at risk was based on 2009 information as this was the mid-point of the 
2005 to 2013 study period. Total department counts of women at risk per age group were 
classified in one of the five geographic regions used in the NDHS.  
In the second step, women at risk were stratified based on the other socio-demographic 
variables of interest. The proportions of women between 20 and 49 years of age for each level of 
education, type of health insurance, and for urban or rural residence were calculated from the 
NDHS data set for each 5-year age group and region of residence. The appropriate proportions 
were then applied to the 2009 population projections for each age group and region of residence 
to generate the necessary strata-specific numbers of at-risk women for subsequent analyses.  
5.2.3. Statistical Analysis 
The total numbers and proportions of CC deaths were described for each category of the risk 
factors of interest using all available data. The same descriptors were calculated for the subset of 
cases with complete information for all potential risk factors of interest. The subsequent analysis 
was completed using two different analytical approaches to evaluate the importance of missing 
risk factor information in the DANE mortality records. The first approach excluded women who 
had unavailable or missing information in any of the variables of interest (complete case 
analysis). The second approach recognised the potential for selection bias by excluding cases 
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with missing data and applied multiple imputation methods with the choice of technique 
informed by the missing data patterns (24). All the analyses were completed in STATA version 
13 (StataCorp LP, College Station, TX, USA). 
5.2.3.1.Complete case analysis 
The first analysis considered only women aged 20-49 years with complete information for all 
of the variables of interest. Associations between each potential risk factor and CC mortality 
stratified by age group were individually evaluated using negative binomial models. The natural 
log of the population at risk stratified by age group and each risk factor was used as the offset in 
these regression models. Risk factors with p-values<0.2 were considered for inclusion in the 
multivariable analysis (25). A Wald test was used to estimate the overall p-value for multi-
category variables. A likelihood ratio test was used to compare the negative binomial to the 
Poisson model (26). Preliminary analysis suggested that a negative binomial distribution fit the 
data better than that a Poisson distribution. 
Multivariable negative binomial regression models were then used to identify differences in 
CC mortality, first by educational level (Model 1) and then by type of health insurance (Model 
2). The decision was made to create two separate models because of the potential for type of 
health insurance to be an intervening variable on the causal pathway between educational level 
and CC mortality. Better education could lead to better insurance which then results in lower CC 
mortality. Correcting for insurance could result in biased underestimates of the direct impact of 
education on CC mortality (25).  
Both models were analysed using the same set of variables (i.e. age group, region of 
residence, and urban or rural residence) to control for potential confounders. Interactions 
between age and educational level, as well as age and type of health insurance were evaluated. 
Pairwise comparisons were used to examine differences in CC mortality among categories of 
education for each age group and across categories of insurance for each age group.  
A third model simultaneously evaluating all independent variables of interest intended to 
measure the joint effect of the education and health insurance did not converge, given that 
109 
stratification of the population at risk resulted in denominators with zero counts. When the cells 
with zero denominators were eliminated, the model did converge, but 15% of the outcome 
observations were lost introducing a risk for selection bias. Interactions were not examined in 
this model. The results of this model were compared to main effects only models with education 
and then with insurance. 
5.2.3.2.Imputed data analysis 
The second approach to the analysis applied multiple imputations to minimise potential biases 
and loss of power and precision associated with missing risk factor data in the DANE mortality 
files. The patterns of missingness were visually assessed using the misstable command  in 
STATA to determine an appropriate method for imputation (24). The result was a table showing 
the percentage of data with various patterns of missingness according to each of the variables. 
Variables were marked as missing or not missing for a given pattern. Multiple imputation by 
chained equations was chosen to optimise the analysis of the socio-demographic factors of 
interest (27), based on the percentage of all women, including those with incomplete data (28), 
who died from CC. 
The method recommended by van Buuren et al (29) was followed to specify the multiple 
imputation model. This model incorporated data from all females who died from CC between 
2005 and 2013 to account for those with missing age and included the socio-demographic 
variables of interest, as well as auxiliary variables. The auxiliary variables considered included 
urban or rural area where the death occurred, facility or place of death (e.g. home, health centre, 
hospital, etc.), marital status, person who certified the death, and year and region of death.  
Using the mean frequency of the imputed data, women aged 20-49 years stratified by age 
groups were again cross-classified according to the risk factors of interest to obtain the number 
of strata-specific CC deaths. Negative binomial models were used to evaluate relationships 
between each socio-demographic factor and CC mortality stratified by age, with the 
corresponding population at risk used to determine the offset as previously described. Risk 
factors with p-values <0.2 were considered for inclusion in the multivariable analysis (25).  
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Two multivariable negative binomial regression models were used to identify differences in 
CC mortality by educational level (Model 1) and type of health insurance (Model 2), as 
described for the complete case analysis. The multiple imputation models also accounted for age 
group, region of residence, and urban or rural residence. As described for the complete case 
analysis, the interactions between age and education and age and type of insurance were 
evaluated.  
Results were reported as incidence rate ratios (IRR) and 95% confidence intervals (95%CI).  
Differences were considered statistically significant if p<0.05. Comparisons between models 
were done used the Akaike’s information criterion (AIC) (25). 
5.3. Results 
From 2005 to 2013, 1,768,273 deaths were reported in Colombia; 756,636 were women of 
any age. During this period, 14,355 women died from CC (code C53 and applicable sub-codes) 
and 2,535 were classified as unspecified malignant neoplasms of the uterus (code C55). From the 
unspecified category, 2,296 (90.6%) cases were reallocated to CC and 239 (9.4%) to corpus 
uterine. Therefore, the number of females of all ages who died from CC was 16,651, which 
corresponded to 2.2% of all deaths in females of all ages during the study period. Seventeen 
women in this group were eliminated from the data set because they resided out of the country, 
resulting in 16,634 women who died due to CC and resided in Colombia in 2005-2013.  
From the 16,634 CC cases (excluding 18 cases with missing age), 5,093 women were aged 
20-49 years, representing 30.6% of all deaths due to CC. The mean age of this group was 40.5
years (SD=6.4). Most women had primary education and subsidised health insurance (Table 5-
1). A third of women lived in the Eastern region and most resided in urban areas of Colombia.  
111 
Table 5-1.  Socio-demographic characteristics of women who died from cervical cancer and 
cases with complete data 












n (%)* n (%)* 
Educational level 
No education 346 (6.8) 334 (7.9) 
Primary 2194 (43.1) 2136 (50.3) 
Secondary 1506 (29.6) 1486 (35.0) 
Higher 294 (5.8) 291 (6.9) 
Missing information 753 (14.8) - - 
Type of health insurance 
Non-affiliated 620 (12.2) 497 (11.7) 
Subsidised 2863 (56.2) 2359 (55.5) 
Special 86 (1.7) 77 (1.8) 
Contributory 1435 (28.2) 1314 (30.9) 
Missing information 89 (1.7) - - 
Urban or rural residence 
Rural 829 (16.3) 687 (16.2) 
Urban 4204 (82.5) 3560 (83.8) 
Missing information 60 (1.2) - - 
Region of residence 
Atlantic 1053 (20.7) 831 (19.6) 
Central 1353 (26.6) 1164 (27.4) 
Pacific 959 (18.8) 826 (19.4) 
Amazon-Orinoquía 167 (3.3) 130 (3.1) 
Eastern 1553 (30.5) 1296 (30.5) 
Missing information 8 (0.2) - - 
Age groups 
20-24 years 64 (1.3) 56 (1.3) 
25-29 years 273 (5.4) 227 (5.3) 
30-34 years 630 (12.4) 541 (12.7) 
35-39 years 1040 (20.4) 872 (20.5) 
40-44 years 1391 (27.3) 1154 (27.2) 
45-49 years 1695 (33.3) 1397 (32.9) 
Women aged 20-49 years who died due to cervical cancer in Colombia 
between 2005 and 2013. The table summarises all available data for women 
who died from cervical cancer and data for women with complete data for 
age, region of residence, educational level, type of health insurance, and rural 
or urban residence. 
*Percentage of total cases in each category.
5.3.1. Complete Case Analysis 
Of the 5,093 women who died from CC, 4,247 (83.4 %) had complete data for all risk factors 
of interest (Table 5-1). The negative binomial models, stratified by 5-year age category, 
identified significant differences in CC mortality among educational levels (Wald test, 
p<0.0001), types of health insurance (Wald test, p<0.0001), urban or rural residence (p<0.0001), 
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and region of residence (Wald test, p<0.0001). Age by itself was also significantly associated 
with CC mortality (Wald test, p<0.0001). 
The final model describing the association between education and CC mortality included rural 
or urban residence, region of residence, and age is presented in Tables 5-2, 5-3, 5-4 and 
Appendix E-1. A significant interaction was detected between educational levels and age groups 
(Wald test, p<0.0001) (Fig. 5-1, Table 5-2 [Model 1], and Table 5-3). Differences in CC 
mortality were observed among women with limited or no education compared to women with 
higher education across all age groups. However, the relative size of these differences tended to 
be larger among younger women than for those in the oldest age group (Table 5-2 [Model 1]). 
For example, when comparing women with primary education to those with higher education, 
the IRR for women aged 25-29 was significantly higher than the IRR for women aged 45-49 
years based on non-overlapping confidence intervals. Larger differences in education also tended 
to be associated with higher IRR for all age groups than smaller differences in education.  
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Fig. 5-1. Marginal mean mortality rates due to cervical cancer according to age groups and 
educational level of women. Mortality rates presented here are adjusted by rural or urban 
residence and region of residence.
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Table 5-2.  Effect estimates for interacting variables in the cervical cancer models limited to complete data (n=4247). 
Associations between educational level or type of health insurance and cervical cancer mortality for each age group (years) 
20-24 25-29 30-34 35-39 40-44 45-49
IRR (95%CI) IRR (95%CI) IRR (95%CI) IRR (95%CI) IRR (95%CI) IRR (95%CI) 
Model 1 
Educational level 
No education vs. higher 
education 32.5 (7.70-137) 14.3 (6.14-33.5) 14.7 (9.30-23.2) 9.27 (6.30-13.6) 11.4 (7.96-16.3) 7.42 (5.42-10.1) 
Primary vs. higher 
education 14.1 (5.27-38.0) 12.4 (7.34-21.0) 5.77 (4.08-8.14) 4.98 (3.69-6.73) 5.96 (4.37-8.13) 4.69 (3.58-6.13) 
Secondary vs. higher 
education 3.87 (1.47-10.2) 3.62 (2.13-6.14) 2.97 (2.10-4.21) 2.65 (1.94-3.60) 2.89 (2.10-3.97) 2.06 (1.54-2.75) 
No education vs. primary 
education 2.30 (0.68-7.77) 1.15 (0.56-2.40) 2.55 (1.75-3.71) 1.86 (1.37-2.53) 1.91 (1.49-2.45) 1.58 (1.26-1.99) 
Model 2 
Type of health insurance 
No insurance vs. 
contributory insurance 1.50 (0.60-3.72) 2.18 (1.43-3.35) 1.54 (1.12-2.13) 1.48 (1.12-1.94) 1.57 (1.21-2.03) 2.21 (1.73-2.81) 
Subsidised vs. 
contributory insurance 1.96 (0.99-3.85) 1.79 (1.27-2.51) 1.74 (1.36-2.21) 1.55 (1.25-1.91) 1.96 (1.61-2.39) 1.96 (1.63-2.37) 
Special vs. contributory 
insurance 2.91 (0.64-13.1) 0.29 (0.04-2.10) 0.64 (0.30-1.39) 0.59 (0.32-1.10) 0.93 (0.61-1.42) 0.79 (0.52-1.19) 
Subsidised vs. special 
insurance 0.67 (0.16-2.82) 6.17 (0.86-44.4) 2.71 (1.26-5.81) 2.61 (1.41-4.83) 2.10 (1.40-3.16) 2.49 (1.6-3.74) 
No insurance vs. special 
insurance 0.51 (0.11-2.44) 7.54 (1.03-55.2) 2.40 (1.09-5.31) 2.49 (1.31-4.73) 1.68 (1.08-2.61) 2.80 (1.82-4.32) 
No insurance vs. 
subsidised insurance  0.77 (0.35-1.68) 1.22 (0.83-1.80) 0.89 (0.66-1.20) 0.95 (0.74-1.23) 0.80 (0.63-1.02) 1.12 (0.90-1.40) 
IRR: Incidence rate ratios; 95%CI: 95% confidence intervals. 
Model 1 assessed differences in cervical cancer mortality rates by educational level and Model 2 evaluated differences in mortality rates by type of health insurance. Both multivariable models 
included fixed effects for age group, urban or rural residence, and region of residence, as well as interactions with age. Only women with complete data for the risk factors of interest were 
included in these analyses. 
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Furthermore, across all education levels, women in older age groups tended to have higher 
mortality rates than those in the youngest age group (Fig. 5-1 and Table 5-3). The relative size of 
differences in risk associated with increasing age also tended to be smaller for women with less 
education compared to women with more education. 
Table 5-3. Effect estimates for the interaction between age and education from complete and 
imputed data models. 
Associations between age group and cervical cancer mortality for each level of education 










25-29 vs. 20-24 1.90 (0.50-7.21) 3.78 (2.32-6.16) 4.03 (2.56-6.34) 4.31 (1.58-11.8) 
30-34 vs. 20-24 6.83 (2.09-22.3) 6.16 (3.86-9.82) 11.6 (7.57-17.8) 15.1 (5.93-38.5) 
35-39 vs. 20-24 7.90 (2.46-25.4) 9.77 (6.18-15.4) 19.0 (12.4-28.9) 27.7 (11.0-69.9) 
40-44 vs. 20-24 10.4 (3.28-33.1) 12.6 (7.97-19.8) 22.2 (14.6-33.8) 29.8 (11.8-75.5) 




25-29 vs. 20-24 2.61 (0.72-9.40) 3.85 (2.47-6.02) 4.46 (2.90-6.87) 4.19 (1.67-10.5) 
30-34 vs. 20-24 7.55 (2.32-24.6) 6.28 (4.09-9.63) 12.5 (8.33-18.9) 13.8 (5.85-32.6) 
35-39 vs. 20-24 10.0 (3.14-32.0) 10.1 (6.65-15.4) 20.6 (13.7-30.8) 25.4 (10.9-59.2) 
40-44 vs. 20-24 13.3 (4.21-42.1) 12.9 (8.52-19.6) 24.1 (16.1-36.0) 28.9 (12.4-67.6) 
45-49 vs. 20-24 15.0 (4.76-47.3) 16.8 (11.1-25.4) 29.4 (19.6-44.0) 47.4 (20.5-110) 
IRR: Incidence rate ratios; 95%CI: 95% confidence intervals. 
Results summarise both the analysis of data for cases with complete information on all risk factors of interest and the imputed data 
analysis for models examining the association between educational level and cervical cancer mortality (Model 1). Both multivariable 
models included fixed effects for age group, urban or rural residence, and region of residence, as well as interactions between 
educational level and age. 
Table 5-4 shows the effect estimates for variables that were not included in the interaction 
between age and educational level in the multivariable model (Model 1). After adjusting for age 
group, region of residence, and urban or rural residence, CC mortality rates were lower among 
women from rural compared to those from urban areas. Mortality rates for women who resided 
in the Atlantic, Central, Pacific, and Amazon-Orinoquía regions were higher than those for 
women from the Eastern region. 
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Table 5-4. Effect estimates for non-interacting variables from of cervical cancer mortality 
models with complete data (n=4247). 




Type of health insurance 
IRR (95%CI) IRR (95%CI) 
Urban or Rural 
residence 
Rural 0.39 (0.35-0.43) 0.52 (0.47-0.57) 
Urban Ref. Ref. 
Region of residence 
Atlantic 1.13 (1.00-1.28) 1.04 (0.92-1.18) 
Central 1.30 (1.15-1.47) 1.28 (1.14-1.44) 
Pacific 1.39 (1.23-1.57) 1.34 (1.18-1.51) 
Amazon-Orinoquía 1.61 (1.32-1.97) 1.64 (1.34-2.01) 
Eastern Ref. Ref. 
IRR: Incidence rate ratios; 95%CI: 95% confidence intervals. 
Model 1 assessed differences in cervical cancer mortality rates by educational level and Model 2 
evaluated differences in mortality rates by type of health insurance. Both multivariable models 
included fixed effects for age group, urban or rural residence, and region of residence, as well as 
interactions with age. Only women with complete data for the risk factors of interest were included 
in these analyses. 
The second multivariable model evaluating the effect of type of insurance showed similar 
results for rural and urban differences and region of residence to Model 1 (Table 5-4 [Model 2] 
and Appendix E-2). However, in this model, there were no differences in CC mortality rates 
between women from the Atlantic and the Eastern regions.  
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Fig. 5-2. Marginal mean mortality rates due to cervical cancer according to age groups and type 
of health insurance of women. Mortality rates presented here are adjusted by rural or urban 
residence and region of residence.
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The second multivariable model also included a significant interaction between the type of 
health insurance and age group (Wald test, p<0.0001) (Table 5-2 [Model 2] and Appendix E-2). 
Mortality rates from CC were higher among women with no insurance and subsidised insurance 
compared to women with contributory insurance, except for women aged 20-24 years (Fig. 5-2 
and Table 5-2 [Model 2]). Also, differences in CC mortality rates were observed between women 
with subsidised and special insurance among women aged 30+ years. Furthermore, mortality 
rates for women with no insurance were higher than women with special insurance, except for 
those aged 20-24 years. There were no significant differences between women with no insurance 
and subsidised insurance in any age group, nor between special and contributory insurance in 
any age group.  
The model including type of health insurance (Model 2 and Appendix E-2) explained a larger 
portion of the total variance in CC mortality (AIC=1099) than the model including level of 
education (Model 1) (AIC=1136) (Appendix E-1).  
In a subset model (n=4,234) examining the simultaneous associations of educational level and 
type of health insurance adjusted for region of residence and rural or urban residence, both 
education (Wald test, p<0.0001) and type of health insurance (Wald test, p=0.02) were 
associated with mortality due to CC. For example, the mortality rate for women with no 
education was higher than that for women with higher education (IRR=9.25; 95%CI=7.56-11.31) 
after adjusting for type of insurance and other risk factors. This was similar to the effect resulting 
from a separate model with educational level (IRR=10.5; 95%CI=8.68-12.70) adjusted for all 
other risk factors except type of insurance but with no interaction term. Also, the mortality rate 
for women with no health insurance was higher than for women with contributory insurance 
(IRR=1.16; 95%CI=1.02-1.33) in the model adjusted for education and other risk factors. This 
result was similar to that obtained using a separate model for type of health insurance (IRR=1.74; 
95%CI=1.53-1.99) adjusted for all other risk factors except education but with no interaction 
term.  
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5.3.2. Missing Data, Multiple Imputation Process, and Imputed Data Analysis 
Most women of all ages who died from CC (n=16,634) had complete information in the 
socio-demographic factors of interest and auxiliary variables (80.3%). Among the variables of 
interest, there were missing values for age (0.1%), educational level (16.3%), type of health 
insurance (1.8%), rural or urban residence (1.0%), and region of residence (0.2%). On the other 
hand, among the auxiliary variables, there were missing values for urban or rural area of death 
(0.2%), facility or place of death (0.2%), and marital status (7.0%). The visual assessment of the 
missing data in the variables of interest, showed a random missing or non-systematic pattern, in 
which the missing values had no special order or distribution. Taking into consideration that 
19.7% of the women of all ages had one or more missing values, 20 imputations by chained 
equations were computed.  
Using the imputed data for all women who died from CC, 5,098 cases were between 20 and 
49 years. This number included five women whose age was missing in the original data and was 
then imputed within the age range of study. The two final multivariable models for CC mortality 
using the imputed data included fixed effects for age, rural or urban area of residence, region of 
residence, and an interaction with age in addition to either level of education or type of insurance 
(Tables 5-5 and 5-6, Appendices E-3 and E-4). The effect estimates for the variables of interest 
that were not interacting for the two models shown in Table 5-5 had the same direction and 
similar effect sizes of the estimates resulting from the complete case analysis (Table 5-4).  
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Table 5-5. Effect estimates for non-interacting variables resulting from the models with imputed 
data (n=5098). 




Type of health insurance 
IRR (95%CI) IRR (95%CI) 
Urban or Rural 
residence 
   Rural 0.39 (0.36-0.43) 0.52 (0.47-0.57) 
   Urban Ref. Ref. 
Region of residence 
   Atlantic 1.20 (1.08-1.34) 1.10 (0.98-1.23) 
   Central 1.25 (1.12-1.40) 1.24 (1.11-1.39) 
   Pacific 1.34 (1.19-1.49) 1.28 (1.14-1.43) 
   Amazon-Orinoquía 1.68 (1.41-2.01) 1.74 (1.45-2.09) 
   Eastern Ref. Ref. 
IRR: Incidence rate ratios; 95%CI: 95% confidence intervals. 
Model 1 assessed differences in cervical cancer mortality rates by educational level and Model 2 
evaluated differences in mortality rates by type of health insurance. Both multivariable models 
included fixed effects for age group, urban or rural residence, and region of residence, as well as 
interactions with age. Data sets including values from the multiple imputations for missing risk 
factor data were included in these analyses. 
Similarly, the pairwise comparisons describing the IRR for CC mortality among educational 
levels and insurance types for each age group using the imputed data (Table 5-6) had the same 
direction and similar effect sizes to the estimates resulting from the complete case analysis 
(Table 5-2). Additionally, differences in mortality rates observed in the imputed data analysis 
between younger and older women for each level of education were similar using the complete 
case data analysis (Table 5-3). The model based on imputed data including the type of health 
insurance (Model 2) also explained a larger portion of the total variance in CC mortality 
(AIC=1138) than the model including the level of education (Model 1) (AIC=1178).  
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Table 5-6. Effect estimates for interacting variables in the cervical cancer models with imputed missing data (n=5098). 
Associations between educational level or type of health insurance and cervical cancer mortality for each age group (years) 
20-24 25-29 30-34 35-39 40-44 45-49
IRR (95%CI) IRR (95%CI) IRR (95%CI) IRR (95%CI) IRR (95%CI) IRR (95%CI) 
Model 1 
Educational level 
No education vs. higher 
education 26.8 (6.65-108) 16.7 (7.93-35.1) 14.7 (9.50-22.6) 10.6 (7.42-15.1) 12.3 (8.90-17.1) 8.49 (6.38-11.3) 
Primary vs. higher 
education 14.0 (5.69-34.6) 12.9 (7.96-21.0) 6.38 (4.61-8.83) 5.60 (4.22-7.43) 6.28 (4.72-8.36) 4.98 (3.87-6.39) 
Secondary vs. higher 
education 3.46 (1.42-8.45) 3.69 (2.26-6.02) 3.15 (2.27-4.36) 2.81 (2.10-3.75) 2.88 (2.15-3.88) 2.15 (1.64-2.81) 
No education vs. 
primary education 1.91 (0.57-6.36) 1.29 (0.69-2.42) 2.30 (1.61-3.27) 1.89 (1.43-2.49) 1.96 (1.57-2.45) 1.71 (1.39-2.09) 
Model 2 
Type of health 
insurance 
No insurance vs. 
contributory insurance 1.55 (0.65-3.67) 2.54 (1.71-3.77) 1.67 (1.24-2.27) 1.71 (1.33-2.21) 1.90 (1.50-2.41) 2.51 (2.01-3.15) 
Subsidised vs. 
contributory insurance 2.06 (1.08-3.94) 2.04 (1.48-2.81) 1.90 (1.51-2.40) 1.79 (1.46-2.19) 2.14 (1.77-2.58) 2.18 (1.82-2.60) 
Special vs. contributory 
insurance 4.01 (1.13-14.3) 0.26 (0.04-1.91) 0.58 (0.27-1.26) 0.55 (0.29-1.02) 0.86 (0.57-1.29) 0.88 (0.60-1.28) 
Subsidised vs. special 
insurance 0.51 (0.16-1.68) 7.76 (1.08-55.8) 3.26 (1.52-6.99) 3.28 (1.78-6.05) 2.49 (1.67-3.70) 2.47 (1.71-3.57) 
No insurance vs. special 
insurance 0.38 (0.10-1.44) 9.66 (1.33-70.4) 2.87 (1.31-6.30) 3.14 (1.67-5.92) 2.21 (1.45-3.38) 2.86 (1.93-4.23) 
No insurance vs. 
subsidised insurance 0.75 (0.36-1.57) 1.24 (0.88-1.76) 0.88 (0.67-1.16) 0.96 (0.76-1.21) 0.89 (0.72-1.11) 1.16 (0.94-1.42) 
IRR: Incidence rate ratios; 95%CI: 95% confidence intervals. 
Model 1 assessed differences in cervical cancer mortality rates by educational level and Model 2 evaluated differences in mortality rates by type of health insurance. Both multivariable models 
included fixed effects for age group, urban or rural residence, and region of residence, as well as an interaction with age. Data sets including values from the multiple imputations for missing risk 




Cervical cancer is a preventable and, if diagnosed early, a treatable disease for many women 
(2). Despite this, the results of the present study reveal that a third of the women who died from 
CC in Colombia during the period of study were between 20 and 49 years. The loss of these 
women has a considerable consequence to young families and an economic impact on the 
Colombian society. Deaths in women of reproductive age could reflect limitations in strategies 
and resources to prevent and treat CC, such as challenges in accessing CC screening previously 
reported in Colombia (30). Screening can have an important impact on reducing CC deaths (31); 
however, to make a meaningful improvement in CC survival, screening needs to be accompanied 
by adequate access to follow-up and treatment options (14, 32). The results of our study suggest 
inequitable access to either or both CC diagnosis and treatment among young women in 
Colombia. 
The present study considered differences in CC mortality for women between 20 and 49 years 
associated with educational level and type of health insurance. The direction and strength of 
these associations were robust regardless of whether complete case or multiple imputation 
analysis was used. This suggests that missing data did not result in meaningful selection bias or a 
substantial loss of precision in the results. The visual assessment of the pattern of missing data 
informed the choice of imputation method and suggested that the data were most likely missing 
at random (33). 
We found differences in CC mortality according to educational level, where a relative gap in 
CC mortality was observed among women with limited or no education compared to women 
with higher education, especially in the youngest groups. Lack of education has been described 
as a factor that perpetuates a vicious circle by limiting access of individuals to crucial 
information to prevent diseases (30), access to health care (34), and the practice of individuals’ 
health care rights (30, 34). Also, low levels of education have been associated with increased 
frequency of riskier behaviours (35). Other studies in Colombia have evaluated the relationship 
between education and mortality from other causes (12, 13, 35). Notwithstanding, the age groups 
considered in these studies differ from the target age groups used in our analysis and women 
with no education were not included as a category in the previous analyses. Moreover, an 
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interaction effect between age and educational level has not been previously explored. Our 
results provide evidence for a social gradient in CC mortality based on educational level which 
has the greatest impact among the youngest women. This finding suggests that improving 
education in young women or developing specific programmes to improve access for women 
with no education or primary education could potentially decrease CC mortality. 
We also observed differences in mortality rates according to health insurance with some 
variations among age groups. In addition to the differences in mortality among women with no 
insurance and those with contributory or special insurance, the observation that having 
subsidised insurance does not decrease CC mortality compared to not having insurance suggests 
the existence of potential limitations in CC diagnosis and cancer care for those with subsidised 
insurance, which could be a result of differences in benefits available as compared to 
contributory insurance (10, 20). Although not demonstrated, late diagnosis and limited access to 
cancer treatment options (9) are potential explanations for the differences in CC mortality rates 
observed according to type of health insurance.  
Additionally, simply having health insurance does not guarantee access to health services (34, 
36). Others have reported that patients face multiple barriers to access health care in Colombia, 
such as distance to health care centres, lack of cultural appropriateness of the services provided, 
political inefficiency, lack of knowledge about patients’ health care rights, and administrative 
barriers imposed by health insurance companies (36). Sanchez et al (34) wrote that, in spite of 
being insured, patients need to pay out-of-pocket for health services or deal with unknown and 
complex administrative formalities imposed by health insurance companies, which delay the 
provision of diagnosis or treatment. Our finding that the models with insurance explained more 
variability in CC mortality than the models with education status, based on their AICs, suggest 
insurance programmes should be also a priority target for interventions to decrease CC mortality 
in Colombia for women between 20 and 49 years of age. 
We also found that mortality rates in urban areas were higher than in rural areas after 
accounting for the effects of age, region of residence, and type of insurance or educational level. 
This result differs from studies conducted in other countries, in which CC mortality rates are 
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high in rural areas (37, 38). However, our results coincide with a previous Colombian study that 
suggests high CC mortality rates in urban areas (11). The authors of the earlier study indicated 
that urban and rural differences in mortality rates could be affected by under-recording of CC 
deaths in areas with high levels of rurality (11). However, others have specified that under-
registration is low in Colombia and should not greatly bias mortality results (13).  
Another plausible explanation for the rural-urban differences found in our study could be that, 
once diagnosed with CC, women living in rural areas often move to urban regions to seek cancer 
treatment and follow-up in better equipped health care centres. Oncologic services are mainly 
concentrated in big Colombian cities (39), forcing many women to leave their homes. 
Furthermore, a qualitative study in Colombia indicated the use persuasive strategies by some 
health insurance companies to convince women to change their address for expediting their 
referral to oncologic centres located in bigger cities (34). If changing addresses is a common 
practice, then, it could be difficult to obtain accurate variations in CC mortality between rural 
and urban areas or even among Colombian regions. 
Furthermore, mortality rates were higher among women living in the Atlantic, Central, 
Pacific, and Amazon-Orinoquía compared to the Eastern region after accounting for other risk 
factors. This finding could be related to social problems reported in departments of these regions 
including poverty or inadequate living conditions (19, 40), lack of access to primary and 
secondary CC prevention (30, 41), or unequal distribution of health care providers (42). This 
might be a further indicator of geographical and socioeconomic difficulties in accessing 
oncologic centres in Colombia. A study from the Colombian National Cancer Institute (9), the 
main cancer centre in the country, showed that 47% of patients seen in the Institute reside 
outside the capital of Colombia.  
Our study is the first assessing CC mortality in Colombia among women aged 20-49 years 
using multivariable regressions to control for confounding by multiple socio-demographic 
variables and for missing values. We identified that CC mortality varied by both level of 
education and type of health insurance according to age groups, incorporating for the first time 
women who had special health insurance and women who did not have education. We made use 
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of multiple databases to obtain the population at risk stratified for the risk factors of interest in 
our analysis. To obtain more complete estimates of CC mortality, cases classified as unspecified 
malignant neoplasms of the uterus were reallocated as CC cases. Additionally, to decrease loss of 
information and prevent potential bias due to missing data, we computed our results using 
multiple imputations in addition to complete case analysis. There was no evidence of substantial 
bias in the estimates from the complete case analysis in this data set. 
The source of denominator data was the most substantial limitation of this study. To examine 
the effect of education, type of health insurance, and urban or rural residence, we made use of the 
best data available to estimate the population at risk for each age group. The distributions of 20-
to-49-years women surveyed in the 2010 NDHS data set were applied to 2009 population 
projections in Colombia. Given that the 2010 NDHS was self-reported data, the distribution of 
the socio-demographic variables used to obtain the population at risk in our study would be 
limited by the quality of the survey results. Challenges with estimating risk factor group-specific 
denominator data for less populated regions also limited our ability to look at the joint effect of 
education and insurance in these data. 
5.4.1. Conclusions 
Gaps in CC mortality between women with limited-to-no-education and highly educated 
women were identified with the greatest disparity in the youngest age groups. We also identified 
that mortality rates were higher among older women. Women with contributory and special 
health insurance had lower mortality due to CC than women with subsidised or no health 
insurance. However, women with subsidised health insurance did not have significantly lower 
CC mortality rates than those with no insurance. This suggests the need to critically review 
access to diagnostic and treatment services for women served by the subsidised insurance plan. 
Information on type of insurance described more variation in CC mortality in the overall study 
population than education status after accounting for other risk factors such as age, rural and 
urban differences, and region of residence. However, education appeared to be a stronger 
individual risk factor when comparing mortality rates among the most and least educated 
women. The detection of inequitable risk ratios for CC mortality in young women associated 
with a number of socio-demographic risk factors represents an opportunity to target efforts to 
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evaluate and improve CC prevention, diagnosis, treatment, and follow-up. Additionally, our 
results can be used to develop and implement interventions to optimise the impact of both 
existing and new resources to prevent premature mortality due to CC in Colombia. 
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CHAPTER 6 – CONCLUSIONS 
Understanding the role socio-demographic factors have in primary and secondary cervical 
cancer (CC) prevention (1-3) and CC mortality (4) in young Colombian women is key for both 
recognising inequities in the distribution of the social determinants of health (SDOH) and 
developing public policies to ensure resources are allocated to decrease the impact of CC in 
Colombian society.  
This thesis identified socio-demographic characteristics associated with awareness of a 
primary prevention strategy and access to secondary prevention for CC. The objectives of this 
thesis also included determining if there were geographic areas with high risk of limited 
awareness of primary prevention or access to secondary CC prevention after accounting for 
previously identified socio-demographic factors. The final objective was to understand the socio-
demographic factors associated with CC mortality among young women in Colombia. The 
purpose of this conclusions chapter is to highlight the most important findings from this work, 
discuss the relevance of the findings, examine strengths and weaknesses of the research, and 
suggest areas for future investigation.  
6.1. Summary of Findings 
This thesis describes inequities in the distribution of the SDOH in relation to CC prevention 
and CC mortality in Colombia. These inequities were expressed as limitations in the awareness 
of the human papillomavirus (HPV) vaccination (1, 3) and restrictions in accessing Pap testing 
(2, 3) faced by young women in Colombia. The mortality rates from CC also varied based on the 
socio-demographic attributes reported in official mortality records (4). The following paragraphs 
present the relevant findings of each of the chapters.  
Chapter 2 reports on differences in the probability of having heard about HPV vaccination 
associated with socio-demographic attributes for women aged 13-49 years (1). This study was 
the first nationwide effort to measure whether women in Colombia were aware of the HPV 
vaccine and how this awareness varied based on their age, educational level, socioeconomic and 
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working status, type of health insurance, urban or rural residence, and region of residence, 
among other factors. The results of this study show a low prevalence of women aware of the 
HPV vaccine and that women in socially disadvantaged conditions were less likely to have heard 
of the vaccine. The results also present significant interactions that show variations in the effects 
of age and region of residence based on the educational level of women, as well as differences in 
the effects of region of residence on having heard about the vaccine by rural or urban area of 
residence.  
The work presented in Chapter 3 goes beyond previous Colombian reports that have used 
classical methodological approaches to evaluate factors associated with Pap testing. National 
data were explored using multilevel multivariable logistic regression to identify whether age, 
educational level, socioeconomic and working status, type of health insurance, living in a rural or 
urban area, region of residence, having children, and whether or not a woman reported making 
her own health care decisions were factors associated with having ever had a Pap test in a group 
of women aged 18-49 years. This analysis was unique in that it also took into consideration the 
role of contextual factors (2). The results of the analysis show that women with better 
socioeconomic conditions, those living in certain geographical regions and living in urban areas, 
as well as women with children were more likely to have had Pap testing. Women whose 
decisions were made by somebody else were less likely to have had Pap testing compared to 
those who made decisions for themselves. The educational level for each woman was an 
important factor to consider in this analysis, as well as the prevalence of no education in the 
neighbourhood where the women lived. The results showed a lower probability of Pap testing 
when the prevalence of no education in women’s neighbourhood increased. In addition, it was 
observed that the effect of education, type of health insurance, age group, and region of residence 
varied with whether women lived in rural or urban areas.   
Chapter 4 extends the questions presented in Chapter 2 and 3 by specifically exploring 
variation in the frequencies of women 13-49 years who had not heard of HPV vaccination and 
women 18-49 years who had not had Pap testing among geographic regions or departments (3). 
This study makes use of a structured methodology never applied before in Colombia to 
investigate spatial variations in access to primary and secondary CC prevention, after accounting 
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for area-based socio-demographic factors. This study reports on the risk ratios for lack of 
awareness of HPV vaccine and failure to have had a Pap smear for each department, after 
accounting for socio-demographic factors of interest from the previous analyses in Chapter 2 and 
3. The spatial clustering and the risk ratio maps presented in Chapter 4 show that living mainly in
socially deprived departments increased the risk of women being unaware of HPV vaccination 
and lacking Pap testing, especially in departments adjacent to the Colombian border. The effect 
of the percentage of women living in rural areas on the lack of Pap testing varied according to 
whether the percentage of women with no education at the department level was above or below 
the national average.  
The analysis presented in Chapter 5 examined associations between mortality rates due to CC 
and socio-demographic factors of women aged 20-49 years (4). This is the first study in 
Colombia to evaluate how socio-demographic factors relate to CC mortality specifically among 
young women. The results of this study show that the mortality rates of women with no 
education or primary education, those with no health insurance or subsidised insurance, women 
from certain geographic regions (i.e. Amazon-Orinoquía, Pacific, and Atlantic regions) and those 
with a rural residence differed from the rates for women with more education, those with 
contributory or special health insurance plans, those who resided in the Eastern region, and 
women from urban areas of Colombia. Larger relative differences in the mortality rates among 
educational levels were observed in younger women compared to older individuals. Also, 
differences in the mortality rates observed among types of health insurance varied among some 
age groups.  
The four studies presented in Chapters 2 through 5 of this thesis identified common risk 
factors associated with the CC prevention and outcome measures of interest. Level of education, 
type of health insurance, having a rural or urban residence, and region of residence were 
consistent socio-demographic drivers of inequities in CC prevention and mortality in Colombia.  
Women with limited or no education had a reduced probability of both having heard of HPV 
vaccination and having had Pap smears. As shown in Chapter 3, having had Pap testing was 
further influenced by the level of education of the neighbourhood where each woman lived, with 
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additional differences for women with rural as compared to urban residences. Women with a 
rural residence were less likely to have Pap testing than women living in urban areas, observing 
wider differences in the odds of Pap testing among women with limited-to-no education 
compared to those with higher levels of education. Additionally, a higher prevalence of no 
education in a neighbourhood resulted in lower odds of having a Pap test in both rural and urban 
areas, especially when comparing women with limited-to-no education to those with secondary 
or higher education. Similarly, the findings presented in Chapter 4 demonstrated that a high 
prevalence of no education at the department level was associated with a low department 
prevalence of Pap tests, specifically in departments classified as being at or above the national 
prevalence of women living in rural areas. Finally, Chapter 5 shows that CC mortality rates were 
higher among women with limited or no education compared to women with higher education, 
observing wider differences in younger age groups.  
 
The type of health insurance was another factor associated with the inequities in CC 
prevention and mortality presented in this thesis. Compared to women with contributory health 
insurance, those having subsidised insurance and women with no insurance had a decreased 
awareness of HPV vaccination. The effect of health insurance on having had Pap testing varied 
by whether women lived in rural or urban areas. Higher prevalences of women with subsidised 
insurance at the department level were further associated with not having heard of HPV 
vaccination and not having Pap testing in Chapter 4. In the case of CC mortality, having 
subsidised insurance and not having insurance were associated with increased CC mortality 
rates, with differences in mortality rates among types of health insurance by age groups. Also, 
there was no a significant difference in CC mortality between women with subsidised insurance 
and those with no insurance, regardless of age.  
 
All chapters in this thesis explored differences between rural and urban residence. Compared 
to living in urban areas, having a rural residence reduced the probability of awareness of HPV 
vaccination, especially in some regions of Colombia, as was observed in the significant 
interaction between urban or rural residence and region of residence. Rural residence was also 
associated with a decreased reporting of having had Pap testing, particularly in some regions of 
the country and among women with no insurance or subsidised health insurance. Additionally, 
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among all levels of education, women living in rural areas had a lower odds of Pap testing 
compared to those in urban areas. Furthermore, the ecological analysis in Chapter 4 identified 
that increases in the percentages of rurality at the department level were associated with an 
increased risk ratio of having more observed than expected cases of women with no Pap, but 
only in departments classified as having a prevalence of no education at or above the national 
prevalence of no education. In contrast, living in rural areas was associated with lower CC 
mortality rates.  
 
Finally, living in the Amazon-Orinoquía region was commonly associated with low 
awareness of HPV vaccination and Pap test uptake and high rates of CC mortality. The results of 
the spatial analyses presented in Chapter 4 confirmed that, after accounting for other risk factors, 
several departments located in the Amazon-Orinoquía and a few departments from the Pacific 
and Atlantic regions (e.g. Chocó, Sucre, and La Guajira) had a higher risk of women not having 
access to primary and secondary CC prevention initiatives relative to the national average.  
 
6.2. Relevance of the Findings 
The results presented in this thesis could inform governmental and non-governmental 
agencies, policy makers, and health care professionals to help improve initiatives currently in 
place to prevent CC in Colombia.  
 
All the chapters comprising this body of work provide new evidence of the impact of socio-
demographic factors on CC prevention and mortality, specifically among young Colombian 
women. The results presented in the previous pages made use of multivariable regression models 
to account for confounding and interactions effects of the risk factors of study, overcoming some 
of the limitations of other studies in the CC prevention and mortality fields reported by other 
Colombian researchers.  
  
The article presented in Chapter 2 is the first nationwide study examining factors associated 
with a primary prevention strategy for CC in Colombia. The study population incorporated 
women aged 13-49 years, expanding the age of participants reported in previous local studies on 
awareness of HPV vaccination in Colombia. The methodology used in this study considered 
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interaction effects to demonstrate that the probability of HPV awareness had a differential impact 
based on the educational level and urban or rural residence of women. This study highlights the 
need for strengthening efforts to educate women in relation to CC, the role of HPV on the 
development of CC, and the importance of HPV vaccination, especially among younger age 
groups, women living in precarious social conditions, those with limited or no education, those 
living in rural areas, and women who lived in socially deprived regions of Colombia. The limited 
awareness of the vaccine by the youngest age groups in this study was a concerning result 
because these are the women in the target groups to receive HPV vaccination. 
 
The methodology used for the analysis of the factors associated with Pap testing presented in 
Chapter 3 considered the potential for clustering in outcome due to similarities in responses 
within neighbourhoods and municipalities by using a multilevel multivariable logistic regression.  
The analysis also considered the potential for contextual effects based on the reported responses 
of other women in the same neighbourhood. The resulting effect of lack of education at the 
neighbourhood level on the probability of Pap testing is a new finding that requires attention 
when planning secondary prevention programmes for CC in Colombia. This contextual effect is 
pointing out that both individual attributes of women and the level of education of the immediate 
area where women reside could limit access to Pap testing. Also, the likelihood of having had a 
Pap test in Colombia was affected by education, type of insurance, age, and region of residence, 
with variations based on whether women had a rural or urban residence. 
 
 Chapter 4 expands on the analysis of the individual risk factors presented in Chapters 2 and 
3, providing an ecological depiction of limitations in access to primary and secondary CC 
prevention programmes in Colombia. This is the first study in the country using global and local 
test for clustering to detect spatial correlations in the department frequencies of having not heard 
of the HPV vaccine and having not had a Pap test. Also, this study provides novel results based 
on the spatial regression models to explain lack of access to primary and secondary CC 
prevention. The finding showing a high risk of lacking access to CC prevention in several 
departments of the Amazon-Orinoquía, Pacific, and Atlantic regions after accounting for other 
known socio-demographic risk factors is a concern that should help identify specific departments 
where the delivery of CC prevention programmes could be enhanced and guide decision makers 
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and health care practitioners to target high-risk areas in Colombia for CC prevention 
programmes. 
 
The analysis of CC mortality in Chapter 5 made use of CC mortality records from 2005 to 
2013 and population projection data made available by the National Administrative Department 
of Statistics of Colombia to examine the importance of socio-demographic risk factors including 
educational level and type of health insurance. Because of preliminary concerns about missing 
data in the mortality records, we compared a complete case analysis to analysis using multiple 
imputation and were able to show that there were no substantial differences in the results of the 
two approaches for these data. Unlike other studies conducted in Colombia, the mortality 
analyses presented in Chapter 5 were specifically focused on young women. This is also the first 
study in Colombia reporting that the relative inequities in CC mortality between highly educated 
and no-to-limited educated women were larger among younger women compared to the older 
women. This finding suggests that improving health care access for women with no or limited 
education or increasing the level of education could hypothetically reduce deaths due to CC. An 
additional remarkable result was that having a subsidised health insurance did not have a 
statistically significant impact on reducing CC mortality compared to not having a health 
insurance. This result implies that women with subsidised insurance face similar barriers to 
access health care than women with no insurance. Based on this result, additional efforts are 
needed to offer women in Colombia the same quality and access to health care benefits, 
regardless of their type of health insurance. The results of this study could guide the evaluation 
of the access that Colombian women have to timely diagnosis and to prompt consideration of the 
potential differences in access to early CC treatment 
 
The findings of this thesis provide an opportunity to improve and develop strategies for CC 
prevention and ensure a prompt access to diagnosis, treatment, and follow-up for young women 
in Colombia. Policy makers and clinicians should be aware of the relevance of individual and 
contextual factors in CC prevention. Health promotion and disease prevention programmes, 
along with increased efforts to improve access of women to formal education, are key 
components to advance in the awareness and knowledge of CC and empower women in taking 
care of their own health. This is especially relevant in rural areas and those Colombian regions in 
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which the current impact of CC prevention programmes have been demonstrated as limited. To 
overcome, in part, the fragmented structure of the Colombian health care system, it is essential to 
create innovative strategies to reach high-risk groups and ensure that women have an equitable 
access to care. It is desirable that these approaches are designed and evaluated in partnership 
with governmental and non-governmental agencies, community organisations, health insurance 
companies, health care providers, and other stakeholders to tailor each approach to the 
characteristics of women living in socially deprived Colombian departments.  
 
6.3. Limitations 
The primary limitations to this thesis are associated with the types of data that were available 
for analysis. The results presented in Chapters 2 through 4 rely on self-reported information 
obtained from the 2010 National Demographic and Health Survey (NDHS). The use of self-
reported data could be a source of information bias, including over-reporting of screening 
participation and recall bias (5). Self-reported data could also lead to an inaccurate prevalence of 
the risk factors under study compared to the real distribution of these factors in Colombian 
women, resulting in misclassification bias. For example, it has been identified that women living 
in socially disadvantaged conditions tend to over-report participation in CC screening 
programmes (6). Artificially inflated screening rates could have an impact on the perceived 
quality of screening programmes (6), giving a sense of confidence to governmental and non-
governmental agencies and health insurance companies with regards to successful CC screening 
coverage rates. Similarly, these inaccuracies could be present when investigating the prevalence 
of women who had heard of the HPV vaccine. The use of self-reported data in the 2010 NDHS 
might have a further impact on the mortality rates presented in Chapter 5, given that the 
population at risk computed for the analysis was based on age-stratified distributions of 
education, type of insurance, and rural or urban residence obtained from women in the NDHS. 
 
The presence of social desirability, a type of information bias, is another problem related to 
self-reported data in the risk factors used in this thesis. Social desirability was defined by Chung 
and Monroe (7) as “the tendency of individuals to underestimate (overestimate) the likelihood 
they would perform an undesirable (desirable) action.” Sensitive questions obtained from the 
2010 NDHS could be a source of social desirability, such as those inquiring about sexual activity 
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or use of contraceptive methods (see Chapter 2), as well as questions about who makes final 
decisions on women’s own health (see Chapter 3). 
 
One more limitation to this thesis could be related to the dependent variable used in Chapter 
2. This variable resulted from the amalgamation of two questions included in the 2010 NDHS. 
Women were asked if they had heard about HPV. If yes, they were also asked if they had heard 
about a vaccine to prevent CC. Women who answered both questions as “yes” were classified as 
having heard about HPV vaccination. The resulting measure evaluates awareness of HPV 
vaccination, but certainly it does not measure women’s level of knowledge about the vaccine. 
Furthermore, in this initial study, the presence of clustering in the data due to neighbourhood and 
municipality was not considered in the formal analysis. This could lead to underestimation of 
standard errors (8, 9) and overestimation of test statistics (9). The use of multilevel analysis is 
recommended to avoid bias due to clustering (8). However, the impact of the failure to account 
for clustering in this analysis should have been relatively small based on comparison to the later 
analysis of the Pap test data. After accounting for the fixed effects in the model presented in 
Chapter 3, the variance partitioning coefficient reflecting the unaccounted differences among 
neighbourhoods and municipalities was 6% and 4.8%, respectively.  
 
Recall and interviewer bias are additional limitations to this thesis. Recall bias could be a 
possible threat to validity in the 2010 NDHS data and the mortality records. However, in the 
NDHS, women would be relatively unlikely to make an error in whether they had heard about 
the HPV and also if they had ever heard about a vaccine to prevent CC. Women would most 
likely have had even less difficulty remembering whether they had a Pap smear before. This 
should have had a relatively little impact on the reported prevalence of the dependent variables 
studied in Chapters 2, 3, and 4. In relation to the mortality data, inconsistencies in the personal 
information of deceased individuals included in the death certificates have been described for 
specific data in Colombia, such as educational attainment, type of health insurance, and urban or 
rural residence (10). The person who completes this information could take it from medical 
records, if available; otherwise, these data could be required to a family member or companion 




The official results of the 2010 NDHS reported compliance with high standards in regards to 
training people who collected the information from participants (11); however, interviewer bias 
could be introduced at any time during the interviewing time, leading to inaccuracy of the 
estimates measured (12). This kind of interviewer bias could affect the quality of data depending 
on how an interviewer asks questions and also based on how characteristics of the interviewer 
might influence answers given by the interviewee (12).  
 
Selection bias could be present in the 2010 NDHS data set, despite the intent to collect the 
data using random sampling techniques (11), given that participation in the survey was 
voluntary. This could result in a sample that differs from the target population (13). Women who 
participated in the 2010 NDHS were those who were at home and those who chose to answer the 
questions.  
 
Limitations associated with missing data and low response rate were not a substantial concern 
for the 2010 NDHS data. The reported overall response rate of the 2010 NDHS was high (92%) 
(11) and there were no missing values in the independent risk factors evaluated. In Chapter 3, 
only 18 women did not supply information about their Pap testing status, representing less than 
1% of missingness in the dependent variable (2). This small percentage of missing values did not 
have an important impact on the estimates. In contrast, the mortality data used in Chapter 5 had 
close to 20% missingness in some of the risk factors of interest and the auxiliary variables, with 
more missing values for educational level, type of health insurance, rural or urban residence, 
region of residence, and age (4). Given that missing values could have an impact on accuracy of 
estimates and reduce statistical power (14), multiple imputation was used during the data 
analysis to prevent bias and loss of power and precision. 
 
Other limitations of this thesis are related to variables that were not available in the data sets 
used for the analyses. For example, although many authors have recognised distance to primary 
and specialised care as a barrier faced by Colombians to access health services (15-19), this 
information was not available in the 2010 NDHS nor in the mortality records. The inclusion of 
distance to a health centre under contract with each woman’s health insurance company could 
have provided further understanding of variations in geographical access to primary or secondary 
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CC prevention, as well as treatment for CC. Also, population density has been associated with 
access to health care, with better access to services when the population density is high (20, 21). 
Chapter 4 included population density as one of the variables in the analysis (3). Incorporating 
population density could have shown whether preventive programmes for CC are reaching 
women living in areas with limited health services or demonstrated a lack of offer of cancer care 
for women living in small cities.  
 
Furthermore, although income is one of the most important SDOH (22) and that a positive 
change in household income has been associated with a better health status of individuals in 
Colombia (23), information about income was unavailable in both the 2010 NDHS and the 
mortality data sets. Including income in the analysis could provide a picture of its relationship 
with access to CC prevention and treatment in Colombia. Measuring the impact of income on CC 
prevention could help health care providers and government entities to reorient CC-related 
services based on the needs of the population. Also, new policies could be developed for 
direction of resources towards regions and areas of Colombia most in need.   
 
6.4. Future Work 
Further studies could build upon the results presented in this thesis to expand the 
understanding CC prevention and mortality among young women in Colombia. Incorporating the 
variables recommended in the previous discussion, such as distance to a health centre and 
income, could provide insights about their impact on access primary and secondary prevention 
and treatment services for CC.  
 
Considering that having knowledge about HPV is central to improve uptake of HPV 
vaccination, further studies using validated and culturally-appropriate surveys could be useful to 
measure the level of knowledge of HPV and HPV vaccination among women by their socio-
demographic characteristics. More complete measurements of knowledge about HPV could, at 
the same time, decrease any potential bias introduced by the dichotomous self-reported data. The 
findings from this study would be helpful for policy makers to modify health education plans to 





As presented in Chapter 3 of this thesis, 13% of Colombian women had never have had a Pap 
test (2). To better understand the socio-demographic risk factors related to compliance with the 
recommendations by the Colombian National Institute of Cancer for Pap testing (24), 
longitudinal studies could be done to evaluate access to Pap test in the last three years. Also, 
given that an adequate follow-up is needed for a meaningful impact of CC screening (25), a 
retrospective study assessing factors related to follow-up among women with abnormal Pap 
smears could reveal areas of improvement in the continuum of care for women with cervical 
lesions. The inclusion of contextual and environmental factors, such as distance to treatment, 
associated with both access to recent Pap testing and proper follow-up would enlighten the role 
of such factors in accessing CC prevention and treatment programmes. To avoid 
misclassification linked with the use of self-reported data, objective information about CC 
screening coverage could be obtained from insurance companies’ records. 
 
In relation to access of women to timely CC diagnosis, the use of the data available from the 
cancer registries in Colombia represents a unique opportunity to study socio-demographic factors 
associated with the stage of CC at the at the time of diagnosis, access to treatment for CC, and 
survival of women with CC. The results of these studies would identify the presence of inequities 
in opportunities to access to medical care by socio-demographic characteristics of women. These 
findings could be useful to further evaluate deficiencies in current primary and secondary CC 
prevention programmes, focusing the attention on possible factors that could be implemented to 
reduce CC mortality in specific groups.  
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) = 𝛽0 + 𝛽1X𝑤𝑒𝑎𝑙𝑡ℎ + 𝛽2𝑋𝑓𝑖𝑛𝑎𝑙_𝑠𝑎𝑦 + 𝛽3𝑋𝑐ℎ𝑖𝑙𝑑𝑟𝑒𝑛 + 𝛽4𝑋𝑤𝑜𝑟𝑘 + 𝛽5𝑋𝑒𝑑𝑢𝑐𝑎𝑡𝑖𝑜𝑛 +
𝛽6𝑋𝑖𝑛𝑠𝑢𝑟𝑎𝑛𝑐𝑒 + 𝛽7𝑋𝑟𝑒𝑔𝑖𝑜𝑛 + 𝛽8𝑋𝑅𝑢𝑟𝑎𝑙/𝑢𝑟𝑏𝑎𝑛 + 𝛽9𝑋𝑎𝑔𝑒 + 𝛽10𝑋𝑛𝑒𝑖𝑔ℎ𝑏𝑜𝑢𝑟ℎ𝑜𝑜𝑑_𝑝𝑟𝑒𝑣_𝑛𝑜_𝐸𝑑𝑢𝑐 +
𝛽11𝑋𝑛𝑒𝑖𝑔ℎ𝑏𝑜𝑢𝑟ℎ𝑜𝑜𝑑_𝑝𝑟𝑒𝑣_𝑛𝑜_𝐸𝑑𝑢𝑐𝑋𝑒𝑑𝑢𝑐𝑎𝑡𝑖𝑜𝑛 + 𝛽12𝑋𝑅𝑢𝑟𝑎𝑙/𝑢𝑟𝑏𝑎𝑛𝑋𝑒𝑑𝑢𝑐𝑎𝑡𝑖𝑜𝑛 +
𝛽13𝑋𝑅𝑢𝑟𝑎𝑙/𝑢𝑟𝑏𝑎𝑛𝑋𝑖𝑛𝑠𝑢𝑟𝑎𝑛𝑐𝑒 + 𝛽14𝑋𝑅𝑢𝑟𝑎𝑙/𝑢𝑟𝑏𝑎𝑛𝑋𝑎𝑔𝑒 + 𝛽15𝑋𝑅𝑢𝑟𝑎𝑙/𝑢𝑟𝑏𝑎𝑛𝑋𝑟𝑒𝑔𝑖𝑜𝑛 +  ν +  μ ,    
 
where the subscripted names represent: 
 wealth: Wealth quintile; reference category=Highest 
 final_say: Final say on health; reference category=Respondent alone 
 children: Having had children or not; reference category= No 
 work: Current working status; reference category= Yes 
 education: Educational level; reference category= Higher 
 insurance: Type of insurance; reference category= Contributory regimen 
 region: Regions of the country; reference category= Eastern 
 Rural/urban: rural/urban area of residence; reference category=Urban 
 age: Group of age; reference category=18 to 24 years old 
 neighbourhood_prev_no_Educ: Prevalence of no education within groups of houses 
 ν error at the municipality level 
 μ error at the neighbourhood level 
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APPENDIX D 
DEPARTMENTS AND REGIONS OF COLOMBIA 
The figure below shows the departments and regions established and used in the 2010 NDHS1  
 
 
                                                 




ADDITIONAL FILES CHAPTER 5 
Table E-1 presents the estimates of the final model using complete data that assessed the 
association between educational level and CC mortality adjusting by rural or urban residence, 
region of residence, and age.  
 
Table E-1. Results of the final model using complete data including the interaction between age 
and educational level (n=4247). 
  IRR (95%CI) Wald test 
p-value 
Educational level   <0.0001 
No education 32.5 (7.70-137)  
Primary 14.1 (5.27-38.0)  
Secondary 3.87 (1.47-10.2)  
Higher Ref.   
Rural or urban residence   <0.0001 
Rural 0.39 (0.35-0.43)  
Urban Ref.   
Region of residence   <0.0001 
Atlantic 1.13 (1.00-1.28)  
Central 1.3 (1.15-1.47)  
Pacific 1.39 (1.23-1.57)  
Amazon-Orinoquía 1.61 (1.32-1.97)  
Eastern Ref.   
Age groups   <0.0001 
25-29 years 4.31 (1.58- 11.8)  
30-34 years 15.1 (5.93- 38.5)  
35-39 years 27.7 (11.0- 69.9)  
40-44 years 29.8 (11.8-75.5)  
45-49 years 49.7 (19.9-124)  
20-24 years Ref.   
Age groups X educational level   <0.0001 
25-29 years X no education 0.44 (0.08-2.34)  
25-29 years X primary education 0.88 (0.29-2.68)  
25-29 years X secondary education 0.93 (0.31-2.82)  
30-34 years X no education 0.45 (0.10-2.05)  
30-34 years X primary education 0.41 (0.14-1.16)  
30-34 years X secondary education 0.77 (0.27-2.15)  
35-39 years X no education 0.29 (0.06-1.27)  
35-39 years X primary education 0.35 (0.13-0.99)  
35-39 years X secondary education 0.68 (0.25-1.89)  
40-44 years X no education 0.35 (0.08-1.54)  
40-44 years X primary education 0.42 (0.15-1.19)  
40-44 years X secondary education 0.75 (0.27-2.07)  
45-49 years X no education 0.23 (0.05-1.00)  
45-49 years X primary education 0.33 (0.12-0.92)  




Table E-2 presents the estimates of the final model using complete data that assessed the 
association between with type of health insurance and CC mortality adjusting by rural or urban 
residence, region of residence, and age.  
 
Table E-2. Results of the final model using complete data including the interaction between age 
and type of health insurance (n=4247). 
  IRR (95%CI) Wald test 
p-value 
Type of health insurance   0.07 
Non-affiliated 1.5 (0.60-3.72)  
Subsidised insurance 1.96 (0.99-3.85)  
Special insurance 2.91 (0.64-13.1)  
Contributory insurance Ref.   
Rural or urban residence   <0.0001 
Rural 0.52 (0.47-0.57)  
Urban Ref.   
Region of residence   <0.0001 
Atlantic 1.04 (0.92-1.18)  
Central 1.28 (1.14-1.44)  
Pacific 1.34 (1.18-1.51)  
Amazon-Orinoquía 1.64 (1.34-2.01)  
Eastern Ref.   
Age groups   <0.0001 
25-29 years 4.69 (2.47-8.91)  
30-34 years 13.4 (7.30-24.8)  
35-39 years 25.4 (13.9-46.4)  
40-44 years 29.1 (15.9-53.1)  
45-49 years 37.6 (20.7-68.4)  
20-24 years Ref.   
Age groups X type of health insurance   <0.0001 
25-29 years X non-affiliated 1.46 (0.53-3.99)  
25-29 years X subsidised insurance 0.91 (0.43-1.95)  
25-29 years X special insurance 0.1 (0.01-1.20)  
30-34 years X non-affiliated 1.03 (0.39-2.70)  
30-34 years X subsidised insurance 0.89 (0.43-1.82)  
30-34 years X special insurance 0.22 (0.04-1.20)  
35-39 years X non-affiliated 0.99 (0.38-2.55)  
35-39 years X subsidised insurance 0.79 (0.39-1.61)  
35-39 years X special insurance 0.2 (0.04-1.04)  
40-44 years X non-affiliated 1.05 (0.41-2.69)  
40-44 years X subsidised insurance 1 (0.50-2.03)  
40-44 years X special insurance 0.32 (0.07-1.53)  
45-49 years X non-affiliated 1.47 (0.57-3.78)  
45-49 years X subsidised insurance 1 (0.50-2.02)  
45-49 years X special insurance 0.27 (0.06-1.29)   
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Table E-3 presents the estimates of the final model using imputed data that assessed the 
association between with educational level and CC mortality adjusting by rural or urban 
residence, region of residence, and age.  
 
Table E-3. Results of the final model using imputed data including the interaction between age 
and educational level (n=5098). 
  IRR (95%CI) Wald test 
p-value 
Educational level   <0.0001 
No education 26.8 (6.65-108)  
Primary 14 (5.69-34.6)  
Secondary 3.46 (1.42-8.45)  
Higher Ref.   
Rural or urban residence   <0.0001 
Rural 0.39 (0.36-0.43)  
Urban Ref.   
Region of residence   <0.0001 
Atlantic 1.2 (1.08-1.34)  
Central 1.25 (1.12-1.40)  
Pacific 1.34 (1.19-1.49)  
Amazon-Orinoquía 1.68 (1.41-2.01)  
Eastern Ref.   
Age groups   <0.0001 
25-29 years 4.19 (1.67-10.5)  
30-34 years 13.8 (5.85-32.6)  
35-39 years 25.4 (10.9-59.2)  
40-44 years 28.9 (12.4-67.6)  
45-49 years 47.4 (20.5-109)  
20-24 years Ref.   
Age groups X educational level   <0.0001 
25-29 years X no education 0.62 (0.13-3.02)  
25-29 years X primary education 0.92 (0.33-2.56)  
25-29 years X secondary education 1.07 (0.39-2.95)  
30-34 years X no education 0.55 (0.13-2.35)  
30-34 years X primary education 0.45 (0.17-1.19)  
30-34 years X secondary education 0.91 (0.35-2.35)  
35-39 years X no education 0.39 (0.09-1.66)  
35-39 years X primary education 0.4 (0.16-1.03)  
35-39 years X secondary education 0.81 (0.32-2.07)  
40-44 years X no education 0.46 (0.11-1.93)  
40-44 years X primary education 0.45 (0.17-1.15)  
40-44 years X secondary education 0.83 (0.33-2.13)  
45-49 years X no education 0.32 (0.08-1.31)  
45-49 years X primary education 0.35 (0.14-0.90)  
45-49 years X secondary education 0.62 (0.24-1.57)   
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Table E-4 presents the estimates of the final model using imputed data that assessed the 
association between with type of health insurance and CC mortality adjusting by rural or urban 
residence, region of residence, and age. 
 
Table E-4. Results of the final model using imputed data including the interaction between age 
and type of health insurance (n=5098). 
  IRR (95%CI) Wald test 
p-value 
Type of health insurance   0.07 
Non-affiliated 1.55 (0.65-3.67)  
Subsidised insurance 2.06 (1.08-3.94)  
Special insurance 4.01 (1.13-14.3)  
Contributory insurance Ref.   
Rural or urban residence   <0.0001 
Rural 0.52 (0.47-0.57)  
Urban Ref.   
Region of residence   <0.0001 
Atlantic 1.1 (0.98-1.23)  
Central 1.24 (1.11-1.39)  
Pacific 1.28 (1.14-1.43)  
Amazon-Orinoquía 1.74 (1.45-2.09)  
Eastern Ref.   
Age groups   <0.0001 
25-29 years 4.73 (2.55-8.75)  
30-34 years 13.5 (7.52-24.3)  
35-39 years 25.2 (14.1-44.9)  
40-44 years 30 (16.9-53.5)  
45-49 years 38.8 (21.8-68.9)  
20-24 years Ref.   
Age groups X type of health insurance   <0.0001 
25-29 years X non-affiliated 1.64 (0.64-4.25)  
25-29 years X subsidised insurance 0.99 (0.48-2.03)  
25-29 years X special insurance 0.07 (0.01-0.69)  
30-34 years X non-affiliated 1.08 (0.43-2.71)  
30-34 years X subsidised insurance 0.92 (0.46-1.83)  
30-34 years X special insurance 0.15 (0.03-0.64)  
35-39 years X non-affiliated 1.11 (0.45-2.74)  
35-39 years X subsidised insurance 0.87 (0.44-1.70)  
35-39 years X special insurance 0.14 (0.03-0.56)  
40-44 years X non-affiliated 1.23 (0.50-3.02)  
40-44 years X subsidised insurance 1.04 (0.53-2.03)  
40-44 years X special insurance 0.21 (0.06-0.81)  
45-49 years X non-affiliated 1.63 (0.67-3.98)  
45-49 years X subsidised insurance 1.05 (0.54-2.06)  
45-49 years X special insurance 0.22 (0.06-0.82)   
 
 
 
